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ABSTRACT 
Cytokines mediate crucial functions in innate and adaptive immunity. They play valuable 
roles in immune cell growth and lineage specification, and are associated with various disease 
pathologies. A large number of low, medium and high throughput studies have implicated association 
of single nucleotide polymorphisms (SNPs) in cytokine genes with diseases. A preponderance of such 
experiments have not shown any causality of an identified SNP to the associated disease. Instead, they 
have identified statistically significant SNP‐disease associations; hence,  it is likely that some of these 
cytokine gene variants may directly or indirectly cause the disease phenotype(s). To fill this knowledge 
gap and derive study parameters for cytokine SNP‐disease causality relationships, we have designed and 
developed the Disease Associated Cytokine SNP Database (DACS‐DB). DACS‐DB has data on 456 
cytokine genes, approximately 61,000 SNPs, and 891 SNP‐associated diseases. In DACS‐DB, among 
other attributes, we present functional annotation, and heterozygosity allele frequency for the SNPs, 
and literature‐validated SNP association for diseases. Users of the DB can run queries such as the ones 
to find disease‐associated SNPs in a cytokine gene, and all the SNPs involved in a disease. We have 
developed a web front end (available at http://www.iupui.edu/~cytosnp  ) to disseminate this 
information for immunologists, biomedical researchers, and other interested biological researchers. 
Since there is no such comprehensive collection of disease associated cytokine SNPs, this DB will be 
vital to understanding the role of cytokine SNPs as markers in disease, and, more importantly, in 
causality to disease thus helping to identify drug targets for common inflammatory diseases.  
Due to the presence of rich annotations, the DACS-DB can be a good source for building a tool for the 
prediction of the “disease association potential (DAP)” of a given SNP. In a preliminary effort to devise 
such a methodology for DAP prediction, we have applied a support vector machine (SVM) to classify 
SNPs. Employing the SNP attributes of function class, heterozygosity value, and heterozygosity standard 
error, 864 SNPs were classified into two classes, “disease” and “non-disease”. The SVM returned a 
xii 
 
classification of these SNPs into the disease and non-disease classes with an accuracy of 74%. By 
modifying various SNP and disease attributes in the training data sets, such a predictive algorithm can be 
extrapolated to identify potential disease associated SNPs among newly sequenced cytokine variations. 
In the long run, this approach can provide a means for future gene variation based therapeutic 
regimens.     
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CHAPTER ONE: INTRODUCTION 
1.1 Cytokines  
Cytokine molecules regulate the innate and adaptive response of the body [1, 36]. They mediate 
lymphopoiesis, myelogenesis and stem cell and tissue differentiation. They play roles in growth and 
development of the body. Cytokines are small proteinaceous molecules with autocrine, paracrine and 
endocrine mode of action.  
         Types of Cytokines 
Cytokines are divided into the following six classes of molecules: 
i.) Interleukins 
ii.) Interferons 
iii.) Chemokines 
iv.) Tumor necrosis factor family 
v.) TGF beta family 
vi.) Growth hormones 
                                       Mechanism of action of Cytokines 
 Cytokines act on the invading pathogens by activation of intermediary molecules that activate T-
cells and B-cells [2]. They also regulate the production of antibodies by B-cells and cell apoptosis 
mediated by monocytes, macrophages and natural killer cells. They also mediate the early line of 
defense of the body and also play roles in the adaptive immune response of the body. Cytokines 
mediate the inflammation occurring in the body and also play role in the growth and differentiation 
of cells.  
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                                        Classification of Cytokines  
Cytokines are classified as proinflammatory and anti-inflammatory. Proinflammatory cytokines 
cause and mediate the inflammation in the body while anti-inflammatory cytokines mediate the 
curbing of inflammation in the body. All the major diseases including inflammatory and auto-
immune diseases are associated with cytokines. Diseases ranging from cancers, cardiovascular 
diseases, diabetes, skin disorders, kidney disorders, psychological disorders ( mood disorders, 
depression, ADHD, bipolar diseases etc.) , Parkinson disease, Alzheimer’s disease, inflammatory 
disorders such as systemic lupus erythematosus, multiple sclerosis and Crohn’s disease have one or 
many cytokines associated with them. 
1.2 SNPs  
      Single nucleotide polymorphism 
Single nucleotide polymorphism is a single nucleotide variation present in the genome of an organism 
and found to be present in at least 1% of the population. This variation is due to the presence of 
different nucleotides in different allelic positions. It can be bi-allelic, tri allelic or tetra-allelic but bi- 
allelic is the most commonly observed variation [4]. This allelic variation is present in similar nucleotide 
sequence and hence can act as marker. 
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 Chr. X: …AGGTCTTG…GATCCTGC….TAAGTAAGGG….TTTGATCA…. 
   Chr. X: …AGGTGTTG…GATCCTGC….TAAGTAAGGG….TTTGTTCA…. 
   Chr. X: …AGGTCTTG…GAACCTGC….TAAGTAACGG….TTTGGTCA…. 
   Chr. X: …AGGTGTTG…GAACCTGC….TAAGTAATGG….TTTGCTCA…. 
 
              Bi-allelic  Tri-allelic Tetra-allelic 
Fig.1: In the four different individuals, in same region of the chromosome X, four different SNPs are 
shown to be present at specific positions among similar nucleotide bases. The first two SNPs are bi-
allelic(G,C),the third is tri-allelic(G,C,T) and the  fourth SNP is tetra-allelic(A,T,G,C).  
“When two random chromosomes are compared, they differ at ~1⁄1000 nucleotides [6]. When all 
chromosomes from 40 individuals are screened, about 17 million SNPs are expected to be found, out of 
the 3 billion bases in human DNA. Only a small proportion of these SNPs are expected to be in coding 
regions, as coding regions are ~1% of the genome and are less likely to have SNPs. Thus, the number of 
coding SNPs is estimated to be ~500,000, which is an average of about 6 SNPs per gene” [3]. 
Comparison to other markers 
 Restriction fragment length polymorphism (RFLP), amplified fragment length polymorphism (AFLP), 
random amplification of polymorphic DNA (RAPD), single sequence repeat (SSR), and expressed 
sequence tags (EST) are the other markers that can be used to characterize a genome. Compared to 
these markers, SNPs are more abundant, less costly and do not require assays for their determination. 
AFLP and SSR are poly-allelic while SNP is bi-allelic causing it to have less fidelity in inheritance. Despite 
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being bi-allelic in nature, SNPs are better biomarkers, as they are present in large numbers in the 
genome [1, 36]. 
            1.3 Literature survey on cytokines, SNPs and diseases  
1.3.1 Cytokines  
            Role and Significance of cytokines 
Cytokines act on the invading pathogens by activation of intermediary molecules that activate T-cells 
and B-cells [1,36]. They also regulate the production of antibodies by B-cells and cell apoptosis mediated 
by monocytes, macrophages and natural killer cells. Cytokine molecules mediate the early line of 
defence of the body and also play a role in adaptive immune response of the body. Cytokines mediate 
the inflammation occurring in the body and also play role in the growth and differentiation of cells.  
Cytokines are classified as Proinflammatory cytokines and anti-inflammatory cytokines. Proinflammatory 
cytokines cause and mediate the inflammation in the body [8] while anti-inflammatory cytokines 
mediate the curbing of inflammation in the body [9]. All the major diseases including inflammatory and 
auto-immune diseases are associated with cytokines ranging from cancers, cardiovascular diseases, 
diabetes, kidney disorders, skin disorders, psychotic disorders ( mood disorders, depression, ADHD, 
bipolar diseases etc.) , Parkinson disease, Alzheimer’s disease and inflammatory disorders such as 
Systemic lupus erythematosus, Multiple sclerosis, Crohn’s disease[2]. 
Cytokine role in bone formation 
Cytokines play a major role in bone formation. IL-11 and IL-6 mediates the generation of osteoclast cells 
while TNF and IL-1 promote the generation of Osteoclast cells by promoting production of IL-11 and IL-6 
cytokines which promote bone loss. IL-6 in combination with IL-3 has been observed to promote 
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osteoclastogenic effects in mice in vitro, while in combination with IL-1 has osteoclastogenic effect in-
vivo. Interleukin-6 has a pathogenetic role in the abnormal bone resorption associated with multiple 
myeloma, Paget's disease, rheumatoid arthritis, and Gorham–Stout disease (also known as vanishing- or 
disappearing-bone disease) [10]. 
Cytokines in diseases  
 IFN-β plays important role in treatment of multiple sclerosis but its role is not completely understood; 
IFN-β might act as an antagonist of endogenous IL-4 and, particularly, IFN-γ; the latter is known to 
exacerbate multiple sclerosis. IFN-β influences the function of the blood–brain barrier by inhibiting cell 
adhesion, cell migration and metalloproteinase activity. It also induces a shift of the cytokine profile to 
an anti-inflammatory phenotype (e.g. TGF-β and IL-10). However, other evidence indicates that IFN-β 
might also up regulate some pro-inflammatory responses, such as IL-12, chemokines and their 
receptors. .IL-1 was the first cytokine detected by bioassay in synovial fluid of patients with Rheumatoid 
arthritis, followed by the demonstration of TNF, IL-6, IL-2, GM-CSF and other, chiefly pro-inflammatory, 
cytokines in cultures of rheumatoid arthritis synovium. IL-1 is regulated by TNF, GM-CSF and immune 
complexes in this disease. Anti-TNF-induced reductions have been noted in levels of IL-6, IL-1, VEGF, IL-8 
and other chemokines in rheumatoid arthritis synovium [11,12,14].  
Th1 cells regulate cell mediated immunity and secrete IL-1, IL-12, IFNᵧ and TNFα. Th2 cells mediate 
humoral immunity and secrete IL-4, IL-5, IL-6, IL-10 and IL-13. IL-4 secreted by TH2 suppresses the 
activity of Th1 cells while IFNᵧ secreted by Th1 cells suppresses the activity of Th2 cells. Crohn’s disease 
is considered Th1 disease while ulcerative colitis is considered having the characteristics of Th2 cells. 
“Models of Inflammatory bowel disease suggest that suppression of activated T lymphocytes may be 
defective in the disease. Lack of IL-10 causes inflammatory bowel diseases but has increased amount of 
IL-1, TNFα, IL-6 and IFNᵧ resulting in suppression of activation of anti-inflammatory cytokines and 
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causing chronic inflammation”. TNFα mediates the production of pro-inflammatory cytokines and alters 
the behavior of cells that are intimately involved in immune response[11].  
Increased synthesis of prostaglandins is a major feature of both acute and chronic inflammatory 
responses and is stimulated by a number of cytokines that are present at inflammatory sites, including 
interleukin 1 (IL-1), tumor necrosis factor (TNF), transforming growth factor β (TGF-β) and platelet-
derived growth factor (PDGF). IL-l and IL-6 are involved in this hyperalgesic response, and that 
production of these cytokines is induced by bradykinin and TNF-α. “Injection of antibodies to IL-1β or IL-
6 attenuates fever and thermogenesis induced by endotoxin, It has been demonstrated that certain 
cytokines (IL-6 and IL-8) elicit fever and thermogenesis via release of Corticotrophin releasing hormone 
(CRH), whereas others (IL-1α and TNF-a) act independently of Corticotrophin releasing hormone (CRH)". 
Severe combined immunodeficiency disease is implicated to be associated with IL-2Rᵧ which is 
component of receptors for IL-4, IL-7, IL-9, IL-15 and IL-21. Th 1 -type responses appear to be involved in 
organ specific autoimmunity, in contact dermatitis, and in some chronic inflammatory disorders of 
unknown etiology. In contrast, in genetically predisposed hosts, Th2-type responses against common 
environmental allergens are responsible for triggering of allergic atopic disorders. Altered profiles of 
lymphokine production may account for immune dysfunctions in some primary or acquired 
immunodeficiency syndromes. Th l -type responses appear to be involved in organ specific 
autoimmunity, in contact dermatitis, and in some chronic inflammatory disorders of unknown etiology. 
In contrast, in genetically predisposed hosts, Th2-type responses against common environmental 
allergens are responsible for triggering of allergic atopic disorders. Altered profiles of lymphokine 
production may account for immune dysfunctions in some primary or acquired immunodeficiency 
syndromes. IFN-α, IL-10, IL-12, and/or transforming growth factor TGF-β produced by macrophages and 
B cells have important effects on CD4+ subset maturation. All but IL-10 preferentially induces Th 1 
expansion in various systems, whereas IL-10 was implicated in Th2 expansion when spleen cells, as 
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opposed to B cells, were used as Antigen presenting cells (APC). IFN-y promotes differentiation to Th I 
cells, both in vitro and in vivo. Interestingly, T cell-independent IFN-y production by natural killer (NK) 
cells in response to IL-12 has recently been reported. Thus, IL-12 may be critical as natural initiator for 
the development of Th 1 responses[16,17,18,19,20]. ”Most striking is the requirement for IL-4 for 
maturation of naive Th cells into Th2 cells. Omenn's syndrome is a rare and severe combined 
immunodeficiency, characterized by hyper eosinophilia and increased serum levels of IgE. IL-4-induced 
IgE molecules are pathogenetically involved in atopy-associated diseases, such as allergic asthma, 
allergic rhinitis, and atopic dermatitis. Hashimoto's thyroiditis or Graves' disease has a clear-cut TH1 
Iymphokine profile with production of high TNF-α and IFN-y concentrations. The levels of IL-6, IL-2, TNF-
α, and IFN-y have been found to be elevated in the serum of patients with active systemic lupus 
erythematosus (SLE) or with particular forms of the disease. Active rheumatoid arthritis contains 
significant amounts of macrophage and/or fibroblast products, including IL- l ,I L-6,I L-8,T NF-
α,"[11,16,18]. In contrast to pro-inflammatory cytokines, T cell-derived lymphokine, such as IL-2, IL-3, IL-
4, IFN-y and TNF-β, are present in synovial fluid of rheumatoid arthritis patients in low concentrations. 
Crohn’s Disease patients produced IL-2 and IFN-y, but not IL-4 and IL-5. Increased production of IL-2, 
TNF-α, and/or IFN-y by CD4 + T cells present in lungs and lymph nodes have been found in active 
sarcoidosis. GM-CSF, TNF-α, and IFN-y are associated with tumors. IL-1β and TNF influence the severity 
of possibly by persistent activation of NF-KB as observed in case of rheumatoid arthritis. IL-1, IL-6, TNF 
are observed with microglia which is constantly observed in neural plaques of rheumatoid arthritis while 
IL-1, IL-6, TNF are observed in astrocytes. IFN-ᵧ and TNF play disease promoting roles multiple sclerosis 
while anti-inflammatory cytokines such as IL-10 and TGF-β are disease down regulating. “IL-2, IL-12 
activates TH1 while IL-2, IFN-ᵧ, TNF-β mediates cell mediated immunity. IL-4, IL-13 activates TH2 cells 
while IL-4, IL-5, IL6, IL-10, 1L-13 released by TH2 cells activates humoral immunity. IL-2, IL-3, IL-4, IL-5, IL-
6, IL-10, GM-CSF, IFN-ᵧ, TNF-β down regulates TH1 cells.  TH1 plays role in viral infections and graft 
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versus host reactions while Th2 plays role in immune memory, allergy and parasite infections, 
proinflammatory cytokines such as TNF, IL-1, IL-6, GM-CSF, and chemokines such as IL-8 are abundant in 
all patients rheumatoid arthritis. This is compensated to some degree by the increased production of 
anti-inflammatory cytokines such as IL-10 and TGF-β and cytokine inhibitors such as IL-1RA and soluble 
TNF-R. TNF-α, TNF-β, IL-6 activate HIV directly through the induction of NF-KB and IL-6 through the 
synergistic effect with TNF-α. IL-2 activated by IL-1 activates T-cells in an autocrine manner. Activated T-
cells produce Cytokines such as TNF-α, TNF-β, IL-3, IL-4, GM-CSF and IL-6 all of which, in turn activates 
HIV replication in T-lymphocytes and macrophages in an autocrine and paracrine manner. IL-6 is a 
growth factor for AIDS Kaposi sarcoma cells while IL-1 and TNF-α are involved in pathogenic mechanism 
of Kaposi sarcoma. TNF-α, IL-1β, viruses [such as CMV (cytomegalovirus)] and bacterial pathogens (such 
as Chlamydia pneumoniae and Helicobacter pylori) can activate NF-κB, which binds to specific sites on 
the promoter regions of target genes. This, in turn, modulates the endothelial synthesis of 
proinflammatory cytokines (IL-1, IL-6 and TNF-α) and chemokines, IL-8, MCP-1 and RANTES (regulated 
upon activation, normal T-cell expressed and secreted). Cytokine stem cell factor GM-CSF and 
erythropoietin relaxed, whereas TNF-α, IL-6 and IL-10 induced contraction of, human arterial segments 
and thus affecting the heart condition. the proinflammatory cytokines TNF-α and IL-1β (but not IL-6) 
induced transient and reversible endothelial dysfunction in humans. High transcardiac levels of soluble 
TNF-αR1 (TNF-α-receptor p55) seem to be protective of endothelial function (probably by inactivating 
circulating TNF-α), high IL-6 and soluble IL-2R (IL-2-receptor) levels were associated with impaired 
microvascular function. IL-6 is the main hepatic stimulus for CRP. Elevated plasma levels of IL-6 and TNF-
α were detected consistently in patients with stable or unstable angina and myocardial infarction. In the 
atherosclerotic plaque, cytokines are released from macrophages, dendritic cells, T-cells, ECs and 
smooth muscle cells (IL-1β, TNF-α, IL-6, IL-8 andMCP-1). The unstable plaque is characterized by 
infiltrating Th1 cells, producing IFN-γ , IL-2, IL-6 and TNF-α. In aged vessels, expression of TNF-α, IL-1β, 
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IL-6, IL-6Rα (IL-6-receptor α) and IL-17 genes was significantly increased compared with young vessels. 
Anti-inflammatory cytokines exerting inhibitory effects on vascular cells include TGF-β, IL-10, TGF-β and 
IL-1ra with acute coronary syndromes in angina patients. proinflammatory cytokines (IL-1, IL-6 and TNF-
α) can exert negative inotropic effects and, therefore, directly modulate cardiac contractility. Obesity 
also leads to a proinflammatory and prothrombotic state that potentiates atherosclerosis. Recent 
findings imply a role for fat-derived ‘adipokines’, including TNF-α, IL-1β, IL-6, IL-8, IL-10, TGF-β and 
adiponectin, as pathogenic contributors or protective factors. Angiogenesis (i.e. the generation of new 
capillary blood vessels from pre-existing vasculature) is potentiated by VEGF, FGF, PDGF and TGF-β and 
via the chemokines MCP-1 and MIP (macrophage inflammatory protein). Cleaved fragments of both 
receptor types, also known as TNF-binding proteins (TNF-BPs), have been detected in the urine and 
serum of patients with a variety of diseases, including cancer, AIDS, and sepsis. TNF is implicated in 
diseases as septic shock, cancer, rheumatoid arthritis, malaria, and other affliction. TNF has also been 
implicated in the pathobiology of cancer cachexia, but its role in this metabolic disease is less well 
defined than in septic shock syndrome. TNF production is increased in macrophages obtained from 
cancer patients. Prolonged exposure of animals to TNF causes cachexia with typical losses of protein, 
lipids, and red blood cell mass. Also, in cancer cachexia, TNF-induced cachexia also causes insulin 
resistance and derangements of glcuose metabolism.” [11-20] 
 
    1.3.2 SNPs  
        SNPs and their significance  
Single nucleotide polymorphism marks the difference of nucleotide composition occurring in individuals 
marked by a difference in nucleotide at a specific location of genome of individuals in a specific 
population and also the variation observed to be found out in at least 1% of the population. SNPs can be 
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causally associated with disease if the variation can result in alteration of amino acid composition 
resulting in change in protein expression and hence causally been associated with disease phenotype; 
these SNPs (missense mutations) are called non-synonymous SNPs. If the nucleotide variation does not 
affect the expression resultant from the nucleotide variation, they are called as synonymous SNPs. SNPs 
can act as the biomarker if they are observed in haplotypes of a particular population for a specific 
phenotypic expression and they can represent the genetic loci as marker for the particular phenotypic 
expression. It can also represent selecting other SNPs as biomarker if the other SNPs are present in 
linkage disequilibrium with the SNP under study. These SNPs can act as the biomarker for the particular 
phenotype and can represent the haplotype for the particular population group. SNPs, hence can be a 
better genetic markers compared to the genes if they can represent the genetic loci with high statistical 
significance for particular phenotypic trait [21, 29, 30].  
SNP role in causality of disease  
SNPs can be responsible for causality of a disease, if the amino acid variation caused by them result in 
change in protein expression and also change in the phenotypic expression which can result in a 
diseased state. This non-synonymous SNP change might be resultant because of mutation brought 
about by the environment factors or the inherent changes in the nucleotide expression resulting 
because of difference in inheritance patterns. If the result of this variation is non-synonymous SNP, it 
can be causally associated with diseases, if the variation is synonymous SNP; it has less possibility of 
being associated with disease. If the non-synonymous SNP is present in exonic region, it has possibility 
of being associated with disease, compared to non-synonymous SNP present in the 5’ UTR, 3’ UTR, near-
gene-5, near-gene- 3 and intron. The same can be true for synonymous SNPs present in the exonic 
region, or non-exonic region. “The SNPs which are present in high linkage disequilibrium to the 
synonymous SNP can be causally associated with disease if they have any cumulative effect on the 
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genetic expression of the genetic element i.e. the change in the haplotypic expression can bring about 
any expression change across the species and bring about change across the species; such a variation 
can be considered to be causally responsible for change in the genetic expression and hence can be 
responsible for a causality of pandemic disease ”.  The causal role of SNPs can be crucial for 
understanding the role of genetic cause of disease at a single nucleotide level which can be crucial in 
understanding the effect of mutational changes on the disease causes, since these mutations when 
inherited and present in at least 1% of the population are classified as single nucleotide polymorphism. 
Most of the SNPs are determined to be associated to diseases statistically and hence they can be said to 
be stochastically associate to diseases, hence the causal association can be established only by biological 
validation.     
SNPs significance as biomarker for diseases  
Before the wide scale study of SNPs, most of the previously studied markers were cytogenetic markers, 
dependent upon the band patterns and the markers were a repeated sequence of nucleotides and they 
are distributed across the genome at regular interval, present in the genome with a unique expression 
pattern .This causes of decrease in expression detection of the biomarkers and also most of the times 
these biomarkers are tri allelic and tetra allelic,  hence their expression biologically does not contain any 
significance; hence SNPs which are  bi-allelic are more prominent and effective as biomarker. SNPs 
which are selected to act as biomarker for the gene are usually present in the genome at  high linkage 
disequilibrium with other SNPs and hence these groups of SNPs as                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
biomarker can represent the haplotype of the population group. Most of the times synonymous SNPs 
can be represented as biomarkers but the synonymous SNPs represent the haplotype instead of 
representing it as a single nucleotide variation. Non-synonymous SNPs can be represented as the 
biomarkers as they have marked effect on the amino acid expression and hence phenotypic expression 
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and hence they can represent the genetic elements which can affect the phenotypic expression 
associated with diseases and can be the biomarker. SNPs most of the time can be suitable marker for 
the diseases and can suitably represent the genetic element for the disease and hence SNPs can be a 
suitable target for treatment of diseases. SNPs as biomarker can be good source for representing the 
drug targets and drug development. SNPs as biomarker can also represent the variations occurring in 
the genome because they can be representative of the genes as they have specific chromosomal 
location with in genes [21, 29, 30, and 31].  
Importance of SNPs as biomarkers  
SNPs as biomarkers can be a specific representation of a gene and they can reduce the genotyping cost 
associated with analyzing a complete gene compared to a single nucleotide. Single nucleotides 
polymorphism when compared with a gene, is easy to genotype and its genetic association can be easily 
determined, as its statistical significance can be easily established.  SNPs as biomarkers can represent 
the genetic element associated with disease and hence can be very important in understanding the 
genetic inheritance of the disease; They can also help understand the evolutionary lineage of a gene’s 
orthology and paralogy associated with genetic evolution. This can also help understand the genetic drift 
and genetic bottleneck phenomena and hence can be crucial in understanding the genetic basis of 
disease being associated with genetic evolution and to be more specific whether they can be associated 
with genetic evolution or not. SNPs as genetic markers can represent the genetic basis of disease 
causality and hence can be crucial in personalized medicine and detecting diseases at an early stage or 
even with the possibility to predict the diseases at early stages; this can also help in predicting the 
diseases for an individual whose genetic make-up can be determined by the knowledge of SNPs present 
in the genome and hence suggesting propensity of occurrence of a disease on the basis of SNP 
composition of the individual in the future. Individuals with specific genetic make-up specifically SNP 
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composition for any individual for a disease can also be a crucial marker for individuals with similar 
genetic composition and hence can pave the path for tailor made medicine and personalized medicines 
also considering the individuals genetic make-up in mind. SNPs as biomarkers can be significant in 
understanding whether the genes associated with linkage disequilibrium as a haplotype can be 
associated with disease and whether they can be representative for other individuals with similar 
nucleotide composition can be associated with diseases or not.  Single nucleotide polymorphism can 
also represent the disease association potential for individuals with particular SNP missing and whether 
it can affect the targeting drugs or not. SNPs can also affect the drug targets and the impact of the drug 
action on the specific drug targets and whether varying the SNP composition can affect the drug activity 
on the individual or not. SNPs with the particular SNP composition which can be varied to a particular 
SNP composition can be associated with disease or not with similar SNP composition or similar 
haplotype pattern [21, 29, 30, and 31].   
         1.3.3 Diseases   
            Cure for diseases  
 Diseases are the disturbances in the natural state of equilibrium of cellular process and proper 
functioning of cellular state and cellular mechanism resulting in healthy state of body. Diseases are 
caused by external factors such as microbes, harsh conditions or imbalance in the cellular defence 
mechanism or disturbance in any of the inherent cellular functions. Diseases can be cured by the 
administration of drugs, proper diet, exercises etc. Any drug which can restore the immune system and 
maintains the cellular mechanism to fight against the invading pathogens can be a cure for the disease. 
Most of the drugs determined are based on the chemical action of drugs on the cellular mechanism or 
immune system to maintain and restore the cellular mechanism to maintain the body equilibrium. Drugs 
designed for specific diseases provide treatment for the disease. There is wide variety of drugs available 
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for treatment of diseases e.g.  Allopathic, homeopathic, Ayurvedic. Most of the drugs designed for 
diseases are based on the chemical methods of synthesis of drugs based on the knowledge of disease 
and chemical nature of disease. Most of the diseases are dependent on drugs treatment and the drugs 
are synthesized on the basis of previous knowledge of the diseases and the chemical composition of 
drugs which can act on the cause of disease and can provide cures for the treatment of disease. Most of 
the drugs synthesized today are chemically synthesized which are not specific for the individuals or the 
treatment of disease has lots of deleterious effects or allergic reactions. Drugs with genetic knowledge 
of the disease can help provide treatment for disease at the earlier stage. This knowledge can provide 
specific knowledge for the treatment of the disease as the exact location of drug target is known which 
can help in making personalized medicine a prominent approach for the treatment for diseases in the 
near future. There are lots of biological markers available for the diagnostics of the genetic cause of 
disease but SNPs as are present in large numbers and they have a specific location with in genome 
seems to be the solution for the treatment of the diseases, as they can, act as the better biomarkers for 
representing genetic causes of diseases when compared to the other biomarkers [22-28]. 
Importance of genetic treatment compared to traditional treatment 
SNPs can act as genetic marker which can provide information on genetic elements which can be target 
for the action of drugs. They can provide a solution for the design of drugs as genetic the knowledge 
about specific genetic element will be known. Drugs as treatment for the cure of diseases are mostly 
dependent on chemical composition but introduction of genetic treatment can provide the treatment of 
disease at an earlier stage as genetic make-up of individual can provide information on predisposition of 
individual to diseases. In the future, most of the diseases can be treated by the genetic treatment and 
also the knowledge of SNPs can increase the understanding of drug-target interaction. Drugs designed 
with keeping SNPs in mind can improve the drug-gene interaction as it can provide the information on 
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specific genetic target for the drugs. This can improve the drug target specificity and improve upon the 
interaction. Drugs designed with the knowledge of SNPs be more specific and efficacious and hence can 
improve upon the interaction drugs and drug targets. This genetic knowledge can provide the better 
models for designing drug targets for treatment of diseases [31].  
Current status of genetic treatment  
SNPs are finding a very important role in pharmacogenetics study as they can provide genetic counseling 
and provide avenue for personalized medicine. Drugs based on SNP analysis are becoming prevalent in 
the market and doctors are prescribing SNP analysis for the patients. SNPs with the pharmacogenetics 
analysis can provide methods for the treatment of the diseases with the information about the genetic 
component for the individual; it can help in explaining the variations which can lead to disease causality 
to the individuals. Several companies provide information on the SNP data which result in the 
association of diseases to drugs and which can provide ample information for designing a personalized 
drug suitable for an individual’s genetic compositions. There are few companies present which provide 
information about genetic composition and SNP details of individuals e.g. 23andMe, Illumina, 454 Life 
sciences, Affymetrix etc.  The current state of genetic treatment with SNP is at the initial stage and only 
involves diagnostic and providing SNP profiling and genetic composition of individuals or SNPs 
associated to groups of diseases. A lot of work is needed to provide genetic treatment and provide drugs 
and personalized care at this stage. It will need some time for personalized medicine and tailor made 
drugs to come into market [31, 32, 34, and 35]. 
Future of genetic treatment of diseases  
Genetic treatment and pharmacogenetics can be the cure for future as the treatment provided by them 
will be more effective and more specific, and this specificity may cause less side reactions and allergy. 
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They can provide cures for the treatment of diseases at the genetic level which will mean premonition of 
disease as the genetic composition can suggest the propensity of an individual to develop a particular 
disease according to the presence of specific SNP composition and presence of SNP in the individual 
genome and the likelihood of a person to develop the disease. Individual genetic makeup can be a 
marker for the drugs to be administered according the genetic profile or the genetic profile of the 
individual race or particular population group or according to the closest genetic makeup SNP profile 
drugs which can have least adverse drug reaction and allergic reaction and specific, effective, more 
reliable treatment for the disease. This knowledge can also help increase the role of understanding the 
role of cytokines and SNPs in the causality of disease and hence making the genetic treatment before 
hand to prevent the disease from occurring in the future. It can improve the pharmacogenetics, 
pharmacokinetics, and genetics behind the cure of diseases and cure of disease with better 
understanding of drug, its target and its development with the knowledge of exact cause of disease.  
This can be vital in understanding and designing the drug and development of drugs in the future with 
more secure, healthy, personalized, target specific, efficacious and much improved drug developed for 
the cure of diseases and treating disease can be easier and preventing mortality because of lack of cure 
for diseases or because of adverse side reactions resulting from action of drugs allergic response by the 
body [31-38].  
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CHAPTER TWO: BACKGROUND 
    2.1 Current state of affairs   
Large numbers of genome wide association studies have established the association of SNPs to diseases. 
With the decreasing cost of genotyping methodology the number of available SNPs is increasing. 
Currently, in the build 132 of dbSNP database, there is a total of 12,212,318 SNP data present for human 
beings.   Currently there are approximately ten SNP databases available online. They are dbSNP, dB GAP, 
Pharm GKB,  SNP500Cancer, HGVBaseG2P, JSNP, F-SNP, HAP MAP, SNP FUNCTIONAL PORTAL, SPSMART, 
FESD, ALFRED, CGAP SNP Index, Forensic SNP index, Gene Viewer, GeneSNP, Genome Variation Server, 
GWAScentral, PhenCode, SeattleSNP, SNAP. Out of these databases F-SNP, HAPMAP, SNP500Cancer 
have information on the phenotype association data and disease information.  
SNP databases with phenotype, disease information  
F-SNP  
This database contains information on functional effects of SNP obtained from 16 different 
bioinformatics tools [32]. Functional effects are predicted and indicated at the splicing, transcriptional, 
translational and post-translational level. F-SNP returns information on gene synonyms, reference DB, 
chromosomal location, description, gene type, functional SNP, chromosomal location and region. It has 
a total number of 115,356 SNP data. 
          HAP MAP  
SNP Information retrieved from TSC (The SNP Consortium) includes observed alleles, submitting lab, 
flanking sequences, genomic location, reported allele frequencies, population type, and protocol [33]. 
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HAP MAP has SNP karyogram information, which provides the option to locate the disease location on 
all the 23 chromosomes. 
     SNP500Cancer 
 It contains information on SNP data involved in cancers and act as resource for identification and 
characterization of genetic variation in genes [34]. SNP data available with SNP500Cancer is a list of 
genes/SNPs, validated sequence results, genotype of each of 102 samples, summary of genotype data 
by sub-populations, primers, probes and conditions for genotyping assays, links to assay ordering 
information, presentation of haplotypes for all genes, GO (gene ontology) pathways, list of genes 
currently under analysis. 
    HGVBaseG2P   
The Human Genome Variation database of Genotype-to-Phenotype information (HGVbaseG2P) provides 
a centralized compilation of summary level findings from genetic association studies, both large and 
small [35]. It has actively gathered datasets from public domain projects, and encourages direct data 
submission from the community. It has information about SNPs associated to the phenotype expression 
studies as it has been found out from several genotype-phenotype association studies. 
         SNPs3D 
 This database has information on the genes and their associated SNPs and diseases [37]. It tries to 
predict the effect of SNP on the structure and profile of the SNP. SNP with negative value is considered 
to be damaging. It predicts the SNP effect by structure and profile. It shows the effect of SNP on the 
molecular effect of the protein structure and also change in the protein structure. The disease 
information is for the genes but there is no information providing association of SNPs to diseases.  
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Genetic Association Database  
GAD database finds the genetic association of gene polymorphism to complex diseases and disorders 
[38]. The disease page contains information on the genes associated, genetic location and disease class. 
The gene page contains genes, different references, OMIM Id, genetic location, disease class, and 
phenotype information while the polymorphism page provide information on disease associated, 
phenotype information, SNP Id and genetic information and different references.       
       Disease association of SNP databases 
All the above described databases available online do not have disease information. These databases 
only provide information about the SNPs and their attribute information. They are specific to population 
groups studied except for HAPMAP which has SNP data available for 11 populations. HGVBase2 
database provides information about genotype to phenotype association, while SNP500Cancer database 
provides information about association of SNPs to cancers while F-SNP database provides information 
about functional effects of SNPs at transcriptional level, splicing level, translational and post-
translational level.  
Current status of Cytokine study and disease association  
Within the last 15 years, the Bidwell group had collected and published information about cytokine 
SNP and disease association. The database was available online at 
http://www.pam.bris.ac.uk/services/GAI/cytokine4.htm but is not available online now.  The database 
contained information on the role of cytokines polymorphism in diseases. Later on three supplements of 
the paper got published in which they added further cytokine polymorphism associated to diseases data 
to the database. In this study Bidwell et. al.[36] showed the effect of allele polymorphism in the cytokine 
genes association to diseases as found in the in vitro studies. They examined the expression studies of 
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cytokines in vivo whether it decreased or increased by the allele polymorphism. The study tried to find 
out whether the effect of cytokine polymorphism affects in vivo expression that can be relevant to 
disease association (J. Bidwell, 1999)[36]. Most of the cytokine polymorphism had suggested the 
association of cytokine genes to diseases. But, as suggested by the example of TNFα and LTA (alias TNFβ) 
the expression level is associated with the cytokine expression; and this association combined with 
linkage disequilibrium study can suggest the association of haplotypes to HLA genes which can be 
associated with diseases; this highlights the effect of cytokine polymorphism on complex diseases.   
Knowledge Gap   
The cytokine polymorphism study performed by the Bidwell et al group had information on 
polymorphism information of 74 cytokine genes. The database contained information on association of 
polymorphism (allelic variation) of cytokines to diseases. The study contained expression data of 
cytokine genes and how the expression in vitro varied for polymorphism.  The database did not have 
information on other important attributes such as chromosome and chromosomal location of alleles, 
function class and other annotation information of the SNPs. Other available SNP databases such as F-
SNP provide information about functional annotation of the SNP, while HapMap database provide 
information about the distribution of SNP across 11 population groups and also the chromosomal 
location of SNP associated with diseases across the 23 chromosomes. SNP500Cancer database provides 
information about the SNPs associated with cancers while HGVBaseG2P database provides information 
about association of genotypes to phenotypes.  But none of these databases provides comprehensive 
information on association of SNPs to diseases for cytokine genes. 
       Need for DACS-DB database  
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DACS-DB database fills this knowledge gap. It has almost combined information of the six 
databases (F-SNP, HAPMAP, SNP-500 Cancer, HGVBaseG2P, SNPs3D, GAD) mentioned above. It 
provides information on association of Cytokines SNPs to diseases with vital information of 
dbSNP identifier and PMID citation to verify the authenticity of SNPId and disease association 
information to cytokine genes. DACS- DB also crucially provide important information on 
attributes of SNPs; chromosome, chromosomal location, function class information and also 
sequence information is very crucial information for drug target identification while including 
heterozygosity value, heterozygosity standard error information can provide along with other 
attribute information can provide annotation information which can be important in 
understanding the causal association of SNPs to diseases. Since, non-synonymous and 
synonymous SNPs have important information for the association of SNPs to diseases, along 
with heterozygosity value can  critically provide association of diseases to SNPs; as SNPs present 
in a coding region have higher possibility of getting associated with diseases as well as SNPs 
present in a non-coding region, regulatory region, promoter region or presence in enhancer or 
silencer region can play a role in the expression of the synonymous SNP in the causality of 
diseases as it can affect the gene expression and gene regulation.   
Goals and objectives for thesis 
Goal  
 The goal of the thesis was to find the causal relation of cytokine SNPs to diseases and to find the 
cytokine SNPs associated with disease data from PubMed literature, curate and annotate the data with 
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SNP and cytokine data and make it available over the web as a database with suitable queries, so that, it 
can be accessed and be retrieved easily by the user.   
Objective of the thesis  
The objective of the thesis was to: 
o Retrieve the SNP data from dbSNP with specific attributes which can 
meaningfully assign value in predicting disease association potential for SNPs. 
o  To retrieve cytokine SNPs associated with diseases as annotated in the relevant 
PubMed literature. 
o  To create a relational database to represent association between Cytokine, 
SNPs and disease tables. 
o  Devise suitable queries to show association between cytokine, SNPs and 
diseases. 
o  To disseminate the database over the web with suitable web interface so that 
the cytokine, SNP and disease data can be retrieved easily. 
o  To build a prediction tool to find disease association potential for newly 
discovered SNPs.  
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CHAPTER THREE   
     MATERIALS AND METHODS 
   3.1 Hardware  
All the work was done on a personal Windows Vista and Windows 7 with a 2 GHz Intel core 2 duo 
processor and 2 GB and 4GB of RAM respectively. 
           Software & Databases  
The database contains data retrieved from different databases available online and from Pubmed 
literature through manual annotation. For the data classification supervised learning method tools were 
utilized for the classifiction purpose. Table 1 shows a list of databases and softwares used for the 
database creation and disease and non-disease classification of SNP based on function class.   
Table 1.) List of software tools and databases used                                                                                                      
      
 
Database/Software Web location/Programming language 
IMMPORT www.immport.org 
DBSNP www.ncbi.nlm.nih.gov/dbSNP 
PUBMED www.ncbi.nlm.nih.gov/pubmed 
SVM LIBSVM 
PERCEPTRON,MLP Python code 
RDF Python code 
E-bot NCBI Eutils tool generates perl code; retrieves data from NCBI 
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         3.2 Procedure 
    3.2.1 Data collection 
Cytokine data collection  
Cytokine data was collected from ImmPort (www.immport.org) an immunological portal containing 
information on immunological genes, pathways, networks, SNP information and genes and pathways 
associated with B cell and T cells and innate and adaptive immunity. The database currently has 
information on 456 cytokine genes. The cytokine data was retrieved in Excel and its content analyzed for 
classification into different cytokine classes before being added to the database. All the attributes of the 
data retrieved from ImmPort were maintained as it was appropriate annotation of the cytokine data 
that we wanted to add to the cytokine table of the database.   
SNP data collection  
SNP data was retrieved from the dbSNP database with the E-utils tools E-bot. A perl code generated 
from E-utils retrieved the dbSNP data in an XML file. This XML file was parsed with perl code in an 
appendix. The SNP data generated was further curated with Perl script to add rs identifier to the SNPId 
which is the unique identifier for the SNPs. The data was curated to add the chromosomal location for 
the SNP with missing chromosomal locations and function class was annotated to include functional and 
non-functional class annotation. Heterozygosity value and Heterozygosity standard error were curated 
to add the values as 0 for their missing values. The data was curated to remove the redundant values of 
SNPs and was cleansed of any repeats and missing values by using the assistance of excel methods.     
            Disease data collection  
Disease data was collected from the PubMed literature cited in the dbSNP database. The data was 
manually retrieved by examining and reading each abstract to look for cytokine SNP association for 
disease and retrieving the relevant disease information from the PubMed abstract. The data was 
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annotated and hyperlinked to the PubMed abstract.  The data was cleansed to remove the duplicate 
values or missing values from the data in Excel by application of Excel functions. 
                                                Cleansing of the data  
The data was cleansed with Microsoft Excel methods and functions. The data was cleaned to 
remove the duplicate rows and missing values. The attributes with wrong data was manually 
curated and missing data was added manually. For part of the additions and deletions, simple 
perl codes were applied to get data in proper format and correct values. All the attributes of 
the SNP, Cytokine and Disease table were manually examined to find the incorrect, repeated or 
missing values. They were either modified, corrected, deleted to ensure the consistency and 
accuracy of the data.  
        3.2.2 Annotation and Curation of the data 
Data was annotated before being added to the database. Cytokine data retrieved from ImmPort was 
different for different cytokine groups and they were combined to make it one group.  All the 
annotation was performed in Excel and the application of Venn diagrams present in the Array track tool 
[http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/default.htm ]. The errors present 
in the data were curated by checking for repeated cytokines and any repetition of cytokines in the 
aliases. Cytokine data was properly annotated and curated but not much work was needed to be done 
as it was retrieved from annotated and curated ImmPort database. SNP and disease data required much 
annotation and curation. For the annotation of the SNP data the data was retrieved with an SQL query 
from the IU Knowledgebase dbSNP server (http://discern.uits.iu.edu:8421) more specifically 
http://discern.uits.iu.edu:8421/dbSNP/dbSNP/ ).   The SNP data was not very comprehensive as there 
were ~11,500 SNP data retrieved and comparing the gene list of SNP data to cytokine genes with Venn 
diagram suggested there were many cytokine genes for which SNP data was missing. This data was 
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curated as it was retrieved by writing the SQL query such that only selected attributes were retrieved 
from the IU knowledgebase dbSNP JDBC server. The retrieved data was manually examined for 
correction of any errors present such as repeated data, missing data or incorrect gene data. Any 
incorrect information was either manually removed or curated by retrieving the correct value from 
dbSNP for the particular gene. SNP data was not complete and not comprehensive; hence it needed to 
be retrieved using other methods. Batch query search available online from dbSNP did not return the 
SNP data in the correct format and it did not return the desired attributes of SNP to be correctly added 
to the database as it would have required a voluminous amount of curation and annotation with Perl 
script. Hence, to ease up the process, data was retrieved with NCBI E-bot tool 
(http://www.ncbi.nlm.nih.gov/Class/PowerTools/eutils/ebot/ebot.cgi ).The following steps were 
employed for data retrieval, annotation and curation. 
i.) The list of cytokine genes was selected from the cytokine data retrieved from ImmPort 
database. 
ii.) The cytokine list was submitted to the bioDBnet (http://biodbnet.abcc.ncifcrf.gov/) to 
change the cytokine list to dbSNP Id. 
iii.) The dbSNP Id retrieved was changed from rsId to numeral identifier, SNPId list with a simple 
Perl script. 
iv.) The retrieved SNPId list was submitted to the E-bot tool and perl code was generated to 
retrieve the full XML record. (Perl code can be located in appendix v) 
v.) The retrieved record was parsed with a Perl code (SNPdataparsing.pl) to retrieve the curated 
SNP data with required SNP attributes. 
vi.) The genes of the SNP data was analyzed with Array-track Venn-diagram tool 
(http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/default.htm ) 
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comparing it to ImmPort cytokine list to find the missing cytokine gene SNP data. Steps i-vi 
were repeated until the entire cytokine gene SNP data was retrieved. 
vii.) The data was analyzed in Excel and part of it with perl script to remove the redundancy and 
locate the missing values. The data was manually examined to add the correct values for the 
incorrect data or to add the missing data from the dbSNP database. Most of the annotation 
and curation of the SNP attributes were done by the Perl code in step v. Remaining missing 
values, redundant values retrieved by the E-bot generated Perl code and repeated values 
generated by step vi data retrieval was manually curated and annotated. Each row and 
column of SNP data was examined manually and the correct annotation was added if 
missing by comparing it to the dbSNP database. Functional class annotation of almost all the 
cytokine SNPs was correctly retrieved and mostly there was error in SNP functional class 
data being retrieved in wrong columns and intermingled with other columns. This needed to 
be manually curated and corrected. Some function class annotation had extraneous 
information such as amino acid mutation information for missense function class, which 
needed to be removed. Also, there was reference function class SNP data with amino acid 
change information, and these SNPs were removed from the data. After addition of data to 
the database, the data was again examined for inconsistencies. And, with the phpMyAdmin 
tool the addition and correction of the data could be performed taking dbSNP as reference. 
Currently curated and annotated number of SNP data in the database is 63,356.    
Disease data was retrieved from a PubMed literature link present for the SNP data in the dbSNP 
database. The entire cytokine gene SNPs with associated PubMed literature was examined and then the 
abstracts were manually read to retrieve the information to be included in the database. The disease 
and SNP association information, if suggested to be found with low p-values, were selected and the 
corresponding attribute information from the abstract was selected and added to the disease data in  
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Excel. This disease data was completely manually curated and annotated and was added to the database 
after careful examination of the data for repetition, missing or incorrect values. Once added to the 
database the data was again examined for inconsistencies as was done with SNP data and the corrected 
mistakes were eradicated. Later a web link record in PubMed database was added by adding the web-
address of the PubMed Id to the Disease table and then by modifying the php script to provide the web 
link to the PMID. The disease data associated to cytokine gene SNP was completely manually curated 
and the attributes link the SNP attributes to the diseases, Cytokine genes, SNPId were verified by the 
web- linked PMID associated abstract. This annotation of disease data provides information on linkage 
of disease to cytokine gene and SNPs and vice versa.   
Later on Cytokine, SNP and Disease tables and corresponding PHP pages were modified to add the NCBI 
cytokine gene address, SNPId dbSNP web address connecting to corresponding NCBI gene and SNP page.   
    3.2.3 Database Schema design 
           3.2.3.1 Data dictionary  
The database dictionary of the database is described in Table 2. 
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Table 2.) Data description of the different attributes present in database 
DACS-DB TABLE ATTRIBUTE DATATYPE DATAVALUE 
CYTOKINE GeneId VARCHAR 50 
CYTOKINE GeneSymbol VARCHAR 50 
CYTOKINE Address VARCHAR 200 
CYTOKINE CytokineFullName  VARCHAR 100 
CYTOKINE Aliases VARCHAR 200 
CYTOKINE Chromosome VARCHAR 20 
SNP Chromosome VARCHAR 10 
SNP GeneSymbol VARCHAR 50 
SNP GeneId VARCHAR 10 
SNP SNPId VARCHAR 20 
SNP ChromosomalLocation VARCHAR  20 
SNP FunctionClass VARCHAR 50 
SNP Allele VARCHAR 10 
SNP HeterozygosityValue VARCHAR 50 
SNP HetStdErr VARCHAR 50 
SNP 5primeSequence blob  
SNP 3primeSequence blob  
Disease GeneId VARCHAR 10 
Disease GeneSymbol VARCHAR 20 
Disease Disease VARCHAR 200 
Disease SNPId VARCHAR 20 
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Disease link VARCHAR 100 
Disease Year VARCHAR 4 
Disease PMID VARCHAR 12 
   
3.2.3.2 E-R diagram  
An Entity-relationship diagram was generated to show the relationship between the Cytokine, SNP and 
Disease tables. It shows the relationships between the tables and the unique identity field which can 
connect the tables. These can be defined as the relationship establishing attributes which suggest 
whether one instance of an attribute in a table is connected with how many instances of the same 
attribute in a connecting table and vice-versa. There is one to one, one to many and many to many 
relationships between the tables. Figure 1 shows the entity relationship diagram for DACS-DB.  
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Fig. 1: Entity-relationship diagram: The relationship between Cytokine, SNP and Disease 
table is represented in the diagram. Cytokine table is connected to the SNP table with 
one to many relationships. The SNP table is connected to the disease table with one to 
many relationships. 
              3.2.4 Database creation 
                                              Creation of the database  
The database was created on the MySQL platform. The database is built on the MySQL 
command prompt.  
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                                                 Creation of the tables                                                                                                                               
The database tables were built on the phpMyAdmin platform. The data dictionary describes the 
data type and data size of the attributes of the three tables. 
                                              3.2.5 Storage of the data  
 All the table values were added to the database from command line with INSERT code for 
adding values from text file. 
            3.2.6 Data definition language and Data manipulation language with PhpMyAdmin    
Database tables were created and updated with DDL commands while data was added and 
deleted  with application of DML commands.                                                                                                               
 3.2.7 Database server  
The database is maintained by the Indiana University, Bloomington cluster of databases. It is maintained 
and updated by the university group of super computers and is the source of the data store house for 
commercial, academic and course work purposes. 
                                                                          Previous server  
The database was previously maintained at https://libra45.uits.iu.edu port no. 3234, now it has 
been stopped. 
                       Latest server  
The database is currently maintained at https://rdc04.uits.iu.edu port no. 3234 and is the current 
active server and the database is maintained on this server. 
           Database server for DACS-DB   
                                                             Current status of the server  
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The database is currently active and is only once a month not available online for monthly 
maintainanace.  
          3.2.8 Web end of the database                                                                      
The database front end is built with PHP and is maintained by the webserve server of Indiana 
University. 
                                   3.2.9 Database Web end 
 The database webend is accessible at webserve.iu.edu and   accessible at the url 
http://www.iupui.edu/~cytosnp.  
           Connecting the database to the web pages  
The database webfront is connected to the database with PHP mysql_connect function and the 
interface for the webpage design purpose is provided by the WinSCP tool. The PHP codes 
written in text editor are saved in the web directory of the webserve and are accessible through 
the hypertext transfer protocol.    
Different web pages present in the database 
 The database has the home page consisting of a header file, a brief note about the database, 
information of the visitor count and the description of the database author and university url. The 
database has webpages on Cytokines, SNP, Diseases, Submission Form and Help/FAQ.  
                               Queries present for the web pages  
The Cytokine page contains information on cytokine and search options with wild card 
character or cytokine search option word by word. The SNP page has search option for the 
search with Chromosome, GeneId, GeneSymbol, SNPId, and FunctionClass. The Disease page 
has search option available with GeneId, GeneSymbol, Disease, SNPId, Year, and PMID. The  
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Submission form web page provides information for submitting SNP, disease, and publication 
information submitted through the email Id. The Help/FAQ webpage contains information 
about the database and provides information about different tables and data and how it can be 
accessed with suitable queries. 
3.2.10 Accessibility of the database  
The database is accessible at the url  http://www.iupui.edu/~cytosnp                 
     3.3 Classification of the data by machine learning approach 
3.3.1 Type and description of data analyzed 
There are approximately 60,438 SNPs associated with 456 cytokines, and approximately 4,667 diseases 
associated with cytokine gene SNPs as cited in numerous PubMed articles.  This work sought to fill the 
knowledge gap between disease-associated cytokine SNPs and disease-causing SNPs.  The data was 
stored as searchable, curated, and annotated cytokine gene SNP data in the DACS‐DB database. DACS‐
DB contains a catalog of manually curated and annotated cytokine genes, their SNPs, and the diseases 
associated with the corresponding cytokine SNPs.  It has comprehensive information on important SNP 
attributes such as function class and heterozygosity value which can be important in understanding the 
causal association of a given SNP to disease.  The database is publicly available as a web resource at 
http://www.iupui.edu/~cytosnp/. 
3.3.1 Data for SVM  
The data was balanced (to ensure the number of records in each class as the same) before taking it into 
any tool.  In doing so, we ended up with 864 records of each class (disease/non-disease).  However, a 
further requirement of SAS Multiple Logistic Regression imposed was in regard to cell sizes based on 
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categorical variables such as our Function Class term.  Using the two categories (coding/non-coding) for 
the Function Class, the cell break down was: 
 Non-coding:  non-disease (851), disease(799) 
 Coding:  non-disease(13), disease(65) 
 
In order for SAS to accurately create a model, it must have a minimum of 10 observations per feature 
(e.g. 10 observations X 2 features = 20) in the smallest cell.  Therefore, our smallest cell of 13 was not 
sufficient for two features.  With this knowledge, we set out to determine why we had so few 
Coding/Non-disease records.  Another analysis of the data revealed the reason: 
o We have many more non-disease records (44,724) than disease records (864)   
o The vast majority of our non-disease records are non-coding (44,166) versus coding (558) 
o When we take a random sample of 864 non-disease records (to match the number of 
disease records), we then naturally only take a few coding records 
 
3.3.2 Retrieval of the data 
 The data for the classification purpose was retrieved from DACS-DB database by the application of the 
following SQL query. 
Query used to extract data from the DACS-DB 
SELECT SNP1.SNPId, SNP1.FunctionClass, SNP1.HeterozygosityValue, Disease.Disease 
FROM SNP1 LEFT OUTER JOIN Disease ON SNP1.SNPId = Disease.SNPId; 
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3.3.3 Cleansing of the data 
 Table 3 shows steps that were applied for the cleansing and classification purpose.  
Table 3: Steps involved in SNP data cleaning, analysis and classification. 
Task 
1.  Develop and execute a query against the DACS-DB SNP and Disease tables to capture SNP ID, 
Function Class, Heterozygosity Value, and Disease.  Place extracted data in an Excel spreadsheet 
(See Appendix 1 for SQL query). 
2. Write a Python script to pre-process the extracted data to: 
a. Remove unwanted rows 
b. Translate Function Code values from text to numeric 
c. Translate the values of Disease from text to numeric, with class 0 = not known to be 
associated with a disease, and class 1 = known to be associated with a disease 
d. Randomly select an equal (to the number of rows in the smaller class) number of rows 
from the larger class and combine with smaller class to create balanced data 
e. Randomize the balanced data 
f. Plot the features to determine if they are linearly separable 
g. Separate the data into 50% training, 25% validation, and 25% testing 
3. If linearly separable, train, validate, and test data with Perceptron 
4. If not linearly separable, train, validate, and test data with Multi-Layer Perceptron 
5. Use a confusion matrix to indicate correct classification percentage 
6. Time permitting, download Support Vector Machine software from the web, train and test the 
data with SVM 
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3.3.4 Classification methods:  A Different Approach 
Data classification begun by analyzing whether there was any good relationship between Function 
Class/Heterozygosity Value and association with a disease. Statistical, Multiple Logistic Regressions 
(MLR), RBF, LDA, SVM were applied for the purpose. There was no linear relationship between 
dependent (disease/no-disease) and multiple independent values. This type of problem applies when 
there is a binary dependent value (disease/no-disease) and multiple independent values (Function Class, 
Heterozygosity Value).  The purpose of the approach was to identify a good MLR model, then translate 
that back (add non-linear terms) to our machine learning model. 
Data input was prepared for a very sophisticated commercial statistical software package, SAS, Version 
9.2. Different variations of different Function Classes that we had used with the MLP (weighted values, 
coding/non-coding values, and unique values) along with Heterozygosity Value were applied.  For all of 
the combinations, SAS indicated that the data did not fit the model.  These findings confirmed we were 
giving SAS a linear model, but the data did not support that model.  In other words, there was no linear 
relationship between Function Class/Heterozygosity Value and Disease. 
 Then data was normalized to improve the linearity of the data. The first method was transforming the 
Heterozygosity Value by taking its natural log. Second, was adding interaction terms.  In this case, a 
value was added to take into SAS that is the product of two existing values such as Function Class X 
Heterozygosity Value; several combinations of values were tried.  In all cases, the data still did not 
support the model. The final technique used with SAS was where terms were squared and cubed (e.g. 
Heterozygosity Value squared and Heterozygosity Value cubed).  Once again, SAS indicated the data still 
did not support the model.  The new approach had only served to verify the relationship between the 
data and was not linear. 
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Examining the Data 
Although statistical software did not provide any relationship between the input terms, it was noticed 
we were keeping a record for each disease to which the SNP was associated.  Therefore, the data was 
over-representing the fact that a given SNP was associated with a disease.  To care for this mistake, logic 
to include a given SNP only once, no matter how many diseases with which it is associated was added. 
Next, the MLP was run again, but this time with the new, smaller dataset.  We first ran with the 
weighted Function Classes.  The error values were about half of what they were before using the smaller 
dataset.  Amazingly, the best MLP was now with 5 hidden units.  However, the Confusion Matrix was not 
very good with only 66% correct classifications.  We then ran the MLP with the coding/non-coding 
Function Classes.  Once again, the best number of MLP hidden nodes was much lower.  However, the 
Confusion Matrix was still not that good with only 68% correct classifications.  Finally, we ran the MLP 
with the unique Function Classes.  After several iterations, the best number of MLP hidden nodes turned 
out to be 22.  The Confusion Matrix was slightly worse at just less than 67% correct classifications.  
Based on these results, the coding/non-coding Function Classes, while not good, were the best 
classifiers.  Just as an experiment, we used this model with the log of the Heterozygosity Value rather 
than just the value.  The percent of correct classifications was worse at 59%. 
We ran RBF (with the coding/non-coding Function Classes) several times using the parameters from the 
Stephen Marshland, Machine learning book;.  The best percent correct of classifications was 68%, the 
same as the MLP. Next, we ran the Linear Discrimant Analysis from the Stephen Marshland, Machine 
learning book with the coding/non-coding Function Classes; It only produced a plot, not a confusion 
matrix.  Therefore, it was to be determined how to use its output.  The way LDA works, it simply 
modifies the data, not the targets.  Consequently, we took its modified data into the same MLP code as 
used above.  We found the best number of hidden nodes to be 22; then MLP was run a few times.  The 
percent of correct classification was comparable to just the MLP using non-LDA input at about 68%.  
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3.3.5 Support Vector Machine 
After analyzing data with the supervised machine learning tools, data was analyzed with the Support 
Vector Machine (SVM) tool, LIBSVM Release 3.1. (it included Windows, Python, and Java solutions 
among many others. It includes four kernels:  linear, polynomial, radial basis function, and sigmoid. RBF 
kernel was chosen for analyzing data based on the recommendation of the LIBSVM guide.  LIBSVM also 
required another software program for graphing to be installed called gnu plot.     
After installing the software, data was added in the format required by LIBSVM.  Its format was 
considerably different, requiring a nearly new Python script. Completing this step for the coding/non-
coding version of the data, checkdata.py script was run. Both our training and testing datasets passed its 
checks. Also included with LIBSVM was a Python script called easy.py that automates the entire process 
of scaling the data, selecting parameters, choosing a model, training the model, and testing the model.  
The documentation indicated it works well for moderately complex data.  However, it did not work that 
well for the data.  It took about half an hour, on the second run; the correct classification percent 
returned was just under 65% and the second run's percent was nearly the same.  Nevertheless, there 
was still hope for improvement.  The guide listed a method of improving this score by running individual 
processes separately, optimizing each of them. However, even before running LIBSVM manually, 
additional changes were made to data (per the LIBSVM guide) and received a score of almost 73%, using 
easy.py.  The data was normalized in Python data preparation script before taking it into the easy.py 
script and the data was scaled in the training dataset and the testing dataset via the LIBSVM Python 
script, scale.py.  The scaled dataset was taken into easy.py.  The result was the best correct classification 
percentage, 72.9%. Also training LIBSVM using combined dataset (both training and testing datasets) as 
input to the LIBSVM grid.py script, the result was an even higher 73.8%. 
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CHAPTER FOUR            
                   RESULTS 
     4.1 Database result  
DACS-DB database is available online and can be accessed at the web address 
http://www.iupui.edu/~cytosnp . The database is available all the time barring once monthly 
maintenance of the database. It can be a source or repository for immunologists, geneticists and 
biomedical researchers to understand the role of genetics behind the cause of diseases and characterize 
the drug targets for the diseases.  
                        Query option result and submission available  
Database has query option available for Cytokine, SNP and Disease tables as shown in the table 4, 
while the submission page has the option of submitting disease, gene , SNP with literature citation 
to the database through email. 
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Table 4.) List of different attributes present in the database with query option to the database. 
Table Query 
Cytokine GeneId 
Cytokine GeneSymbol 
Cytokine CytokineFullName 
Cytokine Aliases 
Cytokine Chromosome 
SNP Chromosome 
SNP GeneSymbol 
SNP GeneId 
SNP SNPId 
SNP FunctionClass 
Diseases GeneId 
Diseases GeneSymbol 
Diseases Disease 
Diseases SNPId 
Diseases Year 
Diseases PMID 
 
              4.2 Cytokine table result 
       Search options 
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 Cytokine table has search option available for GeneId, GeneSymbol, CytokineFullName, Aliases, 
Chromosome. Cytokine table also has a search option available with wild card search. GeneId, 
GeneSymbol, Aliases can be searched with partial word search.  
                              Search results 
 The result of the search is the number of the rows of the data from the table for which the search 
term matches the query in the database. The search result displays the result of the search terms.   
All the 5 attributes of the search term are displayed in the search result along with information 
about the corresponding attributes in the result page. 
                           Cytokine statistics 
 The Cytokine page contains information on 456 Cytokine genes. The following is the statistics and 
pie chart representing the different type of cytokine information and the percentage distribution 
of the Cytokines.  
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Table 5.) List of classes of cytokines and their number and percentage distribution 
Cytokine Total no. Percentage 
Interleukins 47 10% 
Interferons 17 4% 
TNF-family 12 3% 
TGF-β family 33 7% 
Chemokines 102 22% 
Growth hormones 245 45% 
 
 
  Fig. 2 ) Pie chart distribution, Pie-chart of classes of cytokines and number and percentage 
distribution of different cytokines present 
                Cytokine attributes result  
Cytokines contain information about GeneId, GeneSymbol, CytokineFullName, Aliases, 
Chromosomes. These attributes provide information about the annotation of the gene and 
47, (10%) 
17, (4%) 
12, (3%) 
33, (7%) 
102, (22%) 
245, (54%) 
Interleukins
Interferons
TNF family
TGF-β family 
Chemokines
Growth hormones
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different aliases present for the gene to search for the Cytokine.Each  cytokine gene symbol is 
connected to a NCBI gene page which can provide information about the Cytokine genes. 
                      Cytokine Search result  
The following two results display the search result of Chemokines search with CCL as search keyword 
and IL8 gene from the two search options present in the Cytokine page.  
 
 
Fig. 3: Cytokine Search result, Search result of CCL search in the Cytokine search page showing 
different attribute results returned with the wild card search option mainly done to boost the 
search of cytokines with aliases.  
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Fig. 4, Cytokine Search result: Search result of IL8 gene search in the cytokine table showing 
result of IL8 gene search in the cytokine table.   
 
          4.3 SNP TABLE RESULT 
  Search options 
 SNP table has search option present for GeneId, GeneSymbol, Chromosome and FunctionClass. SNP 
data can be searched for any of these attributes and it returns the result for the number of rows present 
for the search term matching the search attributes value to the data in the database.  
 Search results 
 SNP search returns the result for the search term matching the result for the query term matching the 
term in the database and returns the information of the 12 SNP attribute information present in the 
database. The result provides information on the annotation result of the SNP data present for the 
number of the SNP data returned for the query term. This provide important information about the 
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SNPs attribute characteristics such as Function class,  Heterozygosity value, Heterozygosity standard 
error, Allele, Chromosomal position and sequence information.  
SNP statistics  
The SNP page contains information of the 456 Cytokine genes. The following is the statistics and pie 
chart representing the SNP data of different types of cytokine genes and the percentage distribution of 
the SNPs of the cytokines. 
Table 6.) List of SNP data present for Cytokine classes and percentage distribution 
Cytokines No. of SNPs % of SNPs 
Interleukins 4026 7 
Interferons  679 1 
TNF-family 1019 2 
TGF-β family 4426 7 
Chemokines 13372 22 
Growth hormones 36944 61 
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Fig. 5 Pie chart distribution, distribution of SNP data present in different cytokine 
classes and percentage distribution of SNPs data present in different cytokine classes.  
SNP statistics with information on average number of SNP per disease with     publication and average 
number of SNP present without publication (Table 7): There is an average of 71 SNPs present for all 
diseases in the database (top row) while among the diseases with literature evidence for association to a 
SNP (PubMed), this average reduces to two (bottom row). This latter average will increase as more 
publications implying disease-SNP associations are published. 
 
TGF β Family 
Growth hormone
Chemokines
Interferons
TNF family
Interleukins
36944(61%) 
4426 (7%) 
4026(7%) 
1019(2%) 
679(1%) 
13372(22
%) 
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Table 7.) Average number of SNPs present in DACS-DB diseases associated with SNP data present in SNP 
table and SNP data with publication in Disease table 
Total no. of distinct 
diseases present in 
Disease  table 
Total no. of SNP 
present in SNP 
table and Disease  
table 
Average SNP per 
disease present in 
SNP and Disease 
table 
892 63356 71 
892 1734 2 
 
SNP attributes result and download option  
SNP has attribute information on Chromosome, GeneSymbol, GeneId, SNPId, Chromosomal Location, 
Function Class, Allele, Heterozygosity Value, Heterozygosity standard error, 5 prime Sequence, 3 prime 
Sequence. The SNP data can be downloaded in the Excel. 
SNP search result 
 The following search result displays the search result of searching IL7 gene as search query term.  
 
Fig.6 SNP Search result, Search result of IL7 gene in SNP table  
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         4.4 DISEASE TABLE RESULT 
      Search options  
Diseases have the search option available for GeneId, GeneSymbol, Disease, SNPId, Year, and PMID. 
Disease data can be searched for any of these attributes and it returns the result for the number of rows 
present for the search term matching the search attribute value matching to the attribute data in the 
database. 
      Search results  
SNP search returns the result for the search term matching the result for the query term matching the 
term in the database and returns the information of the 6 disease attribute information present in the 
database. The result provides information on the annotation result of the disease for the number of the 
Disease data returned for the query term. This provides important information about the disease 
attributes as GeneId, GeneSymbol, Disease, SNPId, Year, and PMID.  The Disease data for the search 
term GeneSymbol and Disease type has download option available in Excel. 
     Disease statistics  
The disease table has information about 4669 PubMed literature data present for 456 cytokine genes. 
For all the disease data associated with disease there is a PubMed citation for the disease association 
with SNP. There is a total of 1,469 distinct PMID present for disease data and 1,737 distinct SNPId data 
associated with diseases present for the total SNP data. There is a total of 892 distinct disease data 
present for the 456 cytokine genes from the literature study.  
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Disease attributes result and downloads option  
The database provides information about the Disease attributes as GeneId, GeneSymbol, Disease, 
SNPId, Year, and PMID.  The Disease data for the search term GeneSymbol and Disease type has a 
download option available and it can be downloaded in Excel. 
Disease search result  
Figure 7 displays the search result of searching diseases associated with IL9 genes, while figure 8 shows 
the search result for the disease Multiple sclerosis and figure 9 the result for SNPId rs20451.Figure 10 
displays the result of searching 5q31 region associated cytokine, SNPs and diseases with PubMed 
references. 
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Fig. 7 Disease search information, Search result of searching IL7 gene in Disease table. 
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Fig. 8 Disease Search Information, Search result of searching Multiple sclerosis disease in Disease table  
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Fig. 9, SNP search information in Disease table, Result of searching rs20451 SNP in the Disease table 
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Table 8, 5q31 region disease association, Results of the cytokine genes and SNP associated diseases and 
references in 5q31 region are shown in the figure. 
 
4.5 Classification result of SNP into disease and non-disease class 
The results of different predictors and classification methods (supervised learning method) are shown 
below; the best overall correct classification percent was achieved by the SVM, using the coding/non-
coding version of Function Class.  However, both the MLP and LDA methods produced results that were 
nearly as good. 
 Python scripts and methods returned results which varied after multiple runs due to: 
 The random selection of the class with less data to balance the number of records from each 
class (disease/non-disease) 
 The random ordering and also selection of training, validation, and testing subsets 
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Table 9, Classification with different classification tools showing percent correct classification  
Method/Tool Function Class Values Normalization Method Best Network Size 
Percent 
Correct Best in Method 
MLP coding-non-coding unit variance 21 66.20 
 MLP coding-non-coding maximum - minimum 50 71.30 X 
MLP weighted unit variance 3 65.74 
 MLP weighted maximum - minimum 4 66.20 
 MLP unique unit variance 2 69.44 
 MLP unique maximum - minimum 15 68.52 
 RBF coding-non-coding unit variance N/A 50.35 
 RBF coding-non-coding maximum - minimum N/A 65.05 X 
RBF weighted unit variance N/A 56.37 
 RBF weighted maximum - minimum N/A 59.38 
 RBF unique unit variance N/A 50.69 
 RBF unique maximum - minimum N/A 55.56 
 LDA/MLP coding-non-coding unit variance 2 66.20 
 LDA/MLP coding-non-coding maximum - minimum 3 66.90 
 LDA/MLP weighted unit variance 50 72.69 X 
LDA/MLP weighted maximum - minimum 3 69.44 
 LDA/MLP unique unit variance 1 69.44 
 LDA/MLP unique maximum - minimum 3 67.59 
 SVM coding-non-coding SVM N/A 73.84 X 
SVM weighted SVM N/A 66.67 
 SVM unique SVM N/A 64.81 
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             DATA NORMALIZATION RESULT  
Figure 11 represents the classification of the data into disease and non-disease class taking the 
weighted value of function class into consideration. The data is not linearly separable.   
 
 
Fig. 10, Data normalization result, Result displaying the nonlinear result obtained after normalization of 
disease and non-disease class against Function class attribute of SNP.   
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   CHAPTER FIVE 
     DISCUSSION 
      5.1 Significance of cytokines and their role in diseases  
The role of cytokine in diseases can be understood by the realization of their important role they play in 
immune response of body. They regulate the immune response of the body and control the innate and 
adaptive response of the body. This is very significant in the sense that significant numbers of pathways 
that are involved in B cell and T cell regulation are mediated by the mechanism of cytokine action. This is 
underscored by the several literature studies which have implicated the association of cytokines to 
diseases. The knowledge of cytokine genes association to diseases as the database suggest can be an 
important repertoire to understand the immunology behind genetic causes of diseases. This can benefit 
the immunogical and biology community to understand and illuminate the pathways involved in the 
immunology of diseases. The knowledge of biological pathways associated with diseases can provide 
clues on causes of diseases and better targets for drug action and for further concentrating on the 
genetic element which can also be a cause of diseases or potential cause of diseases. The potential 
mechanism of drug action is mostly on the immunological pathways and sometimes genetic elements; 
improving on this knowledge can significantly improve on understanding the diseases and body defense 
mechanism against them and can help in improving the defense mechanism of the body.    
  5.1.1 Significance of the findings of the cytokine SNPs association to diseases  
Several genome wide association studies have implicated the association of SNPs to diseases. As the 
database disease data suggest there are 1737 distinct SNPs associated to diseases. These SNPs can act as 
the biomarker for diseases or can be potential cause of diseases. As, a biomarker they can help target 
the genetic element more correctly. With a linkage disequilibrium study, they can also implicate the 
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association of other genetic elements to diseases. This can further aid in understanding and building the 
pathways of the genes associated to diseases and hence providing broad and probably better 
understanding of the genetics behind immunological action against diseases. SNPs can also causally be 
associated with diseases if they are mutations which effect the expression of the amino acids and hence 
disordered proteins or proteins with different  biological functions which result in causing diseases. 
These mutations can be potential and probably better targets of drug action as they are specific, vary 
from population to population, localized and indicate distinctively known causes of diseases. This 
knowledge can help in designing and defining better drugs for diseases; it can also help in providing 
solution for  tailor made medicine and personalized medicine. SNPs associated to diseases, particularly 
non-Synonymous SNPs can hence help in improving the drug design, defining drug target, target 
validation, improving drug action with increasing specificity and uniqueness of drug action.   
  5.1.2 Characteristic of SNP presence in the Cytokine genetic region associated with disease  
SNPs present in the genetic element of diseases are specific marker for the haplotype which can 
implicate the genetic elements to be associated with diseases or specifically a particular gene to be 
associated with diseases. This can provide information on the association of genetic elements to be 
associated with disease or the evolutionary mechanism behind the causal association of haplotype to 
diseases. The SNP alleles can characteristically be associated with diseases of specific population groups 
if found to be associated with diseases and can even be more specific biomarker for diseases and hence 
the suitable and better site for drug action. This characterizes how the specificity increased by the 
knowledge of SNP can increase the drug selection and drug action; potentially also this suggest a 
mechanism for the knowledge of new drug regimens and with specific disease target known and its 
causality or association biologically validated.    
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   5.1.3 Purpose of the findings and application of the database 
 DACS-DB stores cytokines associated with diseases and specifically Cytokine SNPs associated with 
diseases. This includes the vital information of cytokine SNPs associated to more lethal and prevalent 
diseases such as cancers, heart diseases, auto immune diseases, brain related diseases( Parkinson 
disease, Alzheimer’s disease, ADHD, Bipolar diseases), skin diseases, eye diseases etc. This can provide 
the potential drug targets for diseases. This information can help in understanding the cytokines 
associated with disease pathways and can help in constructing the disease pathways. They can also help 
in building the immune pathways and the cytokines associated can provide vital information on 
understanding and deciphering the innate and adaptive immune response pathways and the mechanism 
of action of B and T cell and the immune regulatory mechanism of disease associated pathways.  
The database can be applicable in providing information about cytokines associated to diseases, SNPs 
associated to diseases, diseases associated to cytokines and diseases associated to cytokine SNPs. This 
can be vital in understanding the biomarker association of SNPs to genetic elements and also providing 
causal association of SNPs to disease. This can be very important information with regards to drug 
design, drug discovery, target discovery, target validation and individualized drug design and 
personalized medicine discovery. In the future, there is a plan to build a disease association potential 
prediction tool which can provide information on disease association potential for newly discovered 
SNPs and hence a new avenue for disease target association and prediction.  
        5.2 Importance of DACS-DB database   
The importance of DACS-DB database can be underscored by the role of SNP information that can be 
helpful in determining the role of causality of diseases and the role of SNP as biomarker to find the 
genetic association of SNP to diseases. This can be helpful in determining whether the diseases can be 
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associated to cytokine SNP. This information can be crucial in understanding the role of genetic causes 
of diseases and whether this knowledge can be helpful in understanding the genetic causes of diseases 
and this can be crucial in understanding the role B-cells and T-cells play in determining the immune 
system of the body. Cytokine knowledge can also be helpful in understanding the role of growth 
hormones in regulating the growth, maintenance and development of the body cells. This play 
important roles in regulating the body homeostasis and proper functioning and regulation of different 
biological processes of the body. There are important cytokines which regulate the innate and adaptive 
immune response of the body, and this knowledge can be crucial in determining the role of Immune 
system and disease interaction and the role it can play role in drug target determination and 
ascertaining the role of the immune system and its associated pathways in drug mediated disease 
regulation. The DACS-DB database can be crucial in assigning the importance of disease causal 
association to genetic causes and hence can be a valuable information source for biomedical 
researchers, immunologists and biologists. 
5.3 Role of DACS-DB in suggesting solution for genetic treatment  
Since the DACS-DB database is a collection of Cytokine SNPs with important diseases associated 
attribute information and disease information along with SNP attributes, and it can prove to be a guide 
for important information on cytokine SNP biomarkers associated with diseases. With chromosomal 
location of a SNP known it can provide information on linkage disequilibrium associated SNP associated 
to a particular SNP which can give information on haplotype associated to a disease which also be a 
suitable biomarker and provide information on association of SNP to a genetic element or genetic 
elements and their association to diseases. The database has information on genetic function class 
which can provide information on whether a SNP can causally be associated to a disease. If a SNP is 
causally associated to disease it can be a suitable drug target as changing it or affecting it can have a 
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positive effect on curing disease. SNP as biomarker can provide information on genetic elements 
associated to diseases as these genetic elements can be suitable drug targets and can assist in drug 
design and checking existing drugs whether they can affect  the existing disease condition or not. Most 
of the diseases have genetic elements and SNPs associated to diseases and they can be a suitable drug 
target for disease treatment and drug development and play important roles in pharmacogenetics 
analysis of disease. SNPs as biomarker can play important role in SNP profiling information and SNP 
composition information of a population group or individual and can provide biomarker for drug effect 
on the particular population group and whether the same drug can be suitable for another population 
group if they have similar genetic profiling. The disease information associated with genetic elements 
can provide information on the genetic cause of diseases and how effecting these genetic elements can 
have effects on treatment of diseases.   Disease associated to Synonymous SNPs (Missense, frame shift, 
non-sense function class) can have information on genetic causality of disease or diseases while 
Synonymous SNPs can be very suitable biomarker for genetic assay and can provide genetic association 
to diseases which can be important in genetic treatment of diseases. Most of the diseases particularly 
immunological compatible one for which cytokines and their SNPs are known , can genetically be 
treated and also, they can be monitored beforehand and prevented before they occur, by modifying the 
disease causing mutation or administering drug to correct the genetic causes which can cause it to 
happen in later stage of life particularly for the individuals and also for the population groups. 
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               CHAPTER SIX 
               CONCLUSION 
The DACS-DB has been designed, developed and published on the web as a user-friendly collection of 
disease associated cytokine gene SNPs. Thus, we present the first catalog of highly annotated cytokine 
SNP data that is searchable for researchers studying genomic variations in diseases. Various types of 
queries can be performed to gain knowledge on cytokines implicated in diseases. Such knowledge 
pertaining to the insinuation of cytokine gene variations in diseases can be useful to immunologists, 
biomedical researchers, pharmaceutical companies etc. and may help understand the genetics behind 
the diseases thus aiding in next generation drug development. 
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APPENDICES: 
Supplement 1: PHP codes of SNP search page. 
<HTML>  
<head><title>SNP Search </title></head> 
<BODY>  
<h1><a href=index.php>Home</a><h1> 
<?php 
echo("<h2><center>SNP search Information</center></h2>"); 
echo("<hr>"); 
/*echo $_POST['searchname'];*/ 
/*echo $_REQUEST['searchname'];*/ 
 import_request_variables('p','p_'); 
 $db= mysql_connect("libra45.uits.iu.edu:3234","root","dis_snp10") or die(mysql_error()); 
       mysql_select_db('dacsdb',$db)or die("Cannot select database."); 
 $result=mysql_query("SELECT * FROM SNP WHERE $p_searchtype like '$p_searchname'"); 
 $result1=mysql_query("SELECT GeneId FROM SNP WHERE $p_searchtype like 
'%$p_searchname%'"); 
 $result2=mysql_query("SELECT GeneSymbol FROM SNP WHERE $p_searchtype like 
'%$p_searchname%'"); 
 $result3=mysql_query("SELECT Chromosome FROM SNP WHERE $p_searchtype like 
'%$p_searchname%'"); 
 $result4=mysql_query("SELECT 
GeneSymbol,GeneId,SNPId,ChromosomalLocation,FunctionClass,Allele,HeterozygosityValue,HetStdErr,5
primeSequence,3primeSequence FROM SNP WHERE $p_searchtype='$p_searchname'"); 
 $columnnos=mysql_num_fields($result4); 
 print "<table cellpadding=0 cellspacing=0 width=100% border=1 >"; 
 for($i=0;$i<$columnnos;$i++) 
  { 
   $attribute_name=mysql_field_name($result4,$i); 
   if($p_searchtype=='Chromosome') 
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   { 
  
 //if($attribute_name=='Chromosome'||$attribute_name=='GeneSymbol'||$attribute_name=='
GeneId'||$attribute_name=='SNPId'||$attribute_name=='ChromosomalLocation'||$attribute_name=='
FunctionClass'||$attribute_name=='Allele'||$attribute_name=='HeterozygosityValue'||$attribute_nam
e=='HetStdErr'){ 
   print "<td align=left><b>".$attribute_name."</b></td>"; 
   } 
   elseif($attribute_name=='Sequence5'||$attribute_name=='Sequence3') 
   { 
   print "<td align=left><b>".$attribute_name.'\''."</b></td>"; 
   } 
  } 
 //print "$p_searchtype"; 
 //print "'$p_searchname'"; 
   if($p_searchtype=='Chromosome') 
   {//print "'$p_searchtype'"; 
   $total=0; 
 while ( $tuple=mysql_fetch_array($result4) ) /* print data of each tuple that meets the search 
query criteria */ 
  { 
  print "<tr>"; 
  $total++; 
   for ( $i=0;$i<$columnnos;$i++ ) 
   { 
   $attribute_value=$tuple[$i]; 
   print "<td align=left>".$attribute_value . "</td>"; 
 
   } 
  } 
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 } 
 mysql_free_result($result4);   
  
 if($p_searchtype=='GeneSymbol'||$p_searchtype=='GeneId'||$p_searchtype=='SNPId'||$p_se
archtype=='FunctionClass') 
 { 
  /*echo $p_searchname;*/ 
  /*echo $p_searchtype;*/ 
  $ncols=mysql_num_fields($result);/* How many columns (fields) */ 
  print "<table cellpadding=0 cellspacing=0 width=100% border=1 >"; 
  print "<tr>"; 
  for ( $i=0; $i <$ncols; $i++ )  
  { 
  if($i==0||$i==1||$i==2){next;} 
  else{ 
   
  $column_name=mysql_field_name($result,$i); /* field name */    
   print "<td align=left><b>".$column_name."</b></td>"; 
  }} 
   print "</tr>"; 
 $total=0; 
  while ( $row = mysql_fetch_array($result) ) /* process result row-by-row */ 
 {  
  print "<tr>"; 
  $total++; 
  for ( $i=0; $i <$ncols; $i++ )  
  { 
  if($i==0||$i==1||$i==2){next;} 
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  else{ 
   $column_value=$row[$i];            /* field value */ 
   print "<td align=left>".$column_value . "</td>";  
 
  }} 
 } 
 } 
 mysql_free_result($result);  
 echo ("<form method=get action=cleanData1.php>"); 
 echo ("<form method=get action=cleanDataCs.php>"); 
 if($p_searchtype==GeneId){ 
 $row1 = mysql_fetch_array($result1);$row3 = mysql_fetch_array($result3);$row2 = 
mysql_fetch_array($result2); 
 echo ("<h3>Search for ".$p_searchtype ." ".$p_searchname." "."GeneSymbol"." ".$row2[0]." 
"."located on chromosome"." ".$row3[0].  ": ". $total." records found</h3>");} 
 elseif($p_searchtype==GeneSymbol){  
 $row1 = mysql_fetch_array($result1);$row3 = mysql_fetch_array($result3);$row2 = 
mysql_fetch_array($result2); 
 echo ("<h3>Search for ".$p_searchtype ." ".$p_searchname." "."GeneId"." ".$row1[0]." 
"."located on chromosome"." ".$row3[0].  ": ". $total." records found</h3>"); 
 echo("<p align=\"left\"><a 
href=\"cleanData1.php?searchtype=$p_searchtype&searchval=$p_searchname\">Click here to 
download</a></p>"); 
 } 
 elseif($p_searchtype==Chromosome){  
 //$row1 = mysql_fetch_array($result1);$row3 = mysql_fetch_array($result3);$row2 = 
mysql_fetch_array($result2); 
 echo ("<h3>Search for ".$p_searchtype ." ".$p_searchname.  ": ". $total." records 
found</h3>");echo("<p align=\"left\"><a 
href=\"cleanDataCs.php?searchtype=$p_searchtype&searchval=$p_searchname\">Click here to 
download</a></p>");}//" "."GeneId"." ".$row1[0]." "."located on chromosome"." ".$row3[0].  ": ". 
$total." records found</h3>");} 
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 elseif($p_searchtype==FunctionClass){  
 echo ("<h3>Search for ".$p_searchtype ." ".$p_searchname.  ": ". $total." records 
found</h3>");}//" "."GeneId"." ".$row1[0]." "."located on chromosome"." ".$row3[0].  ": ". $total." 
records found</h3>");} 
 elseif($p_searchtype==SNPId){  
 echo ("<h3>Search for ".$p_searchtype ." ".$p_searchname.  ": ". $total." records 
found</h3>");}//" "."GeneId"." ".$row1[0]." "."located on chromosome"." ".$row3[0].  ": ". $total." 
records found</h3>");} 
 //echo ("<br><left><h1><a href=www.google.com> Google </a></h1></center>"); 
 //echo ("<br><left><h1><a href=Cytokine_SNP.php> Back</a></h1></center>"); 
 echo ("<hr>"); 
?>  
</BODY>  
</HTML> 
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Supplement 2 Disease search PHP code 
<?php 
echo("<HTML><head><head><title>Disease Information </title></head>"); 
echo("<BODY>"); 
echo("<h1><a href=index.php>Home</a></h1>");//echo ("<br><left><h1><p align=\"right\"><a 
href=Cytokine_associated_diseases.php> Back</a></h1></center>"); 
echo("<h2><left>Disease Information</left></h2>"); 
echo("<hr>"); 
/*echo $_POST['searchname'];*/ 
/*echo $_REQUEST['searchname'];*/ 
 import_request_variables('p','p_'); 
 $db= mysql_connect("libra45.uits.iu.edu:3234","root","dis_snp10") or die(mysql_error()); 
       mysql_select_db('dacsdb',$db)or die("Cannot select database."); 
 $result=mysql_query("SELECT *  FROM Disease WHERE $p_searchtype like 
'%$p_searchname%'"); 
 $result1=mysql_query("SELECT Disease,SNPId,link,Year,PMID  FROM Disease WHERE 
$p_searchtype like '%$p_searchname%'");//='$p_searchname'");// 
 $result2=mysql_query("SELECT GeneId,GeneSymbol,Disease,SNPId,link,Year,PMID  FROM 
Disease WHERE $p_searchtype like '%$p_searchname%'"); 
 $result3=mysql_query("SELECT GeneId,GeneSymbol,Disease,SNPId,link,Year,PMID  FROM 
Disease WHERE $p_searchtype like '%$p_searchname%'"); 
 $result4=mysql_query("SELECT GeneId,GeneSymbol,Disease,SNPId,link,Year,PMID  FROM 
Disease WHERE $p_searchtype like '%$p_searchname%'"); 
 //mysql_free_result($SNP); 
   /*echo $p_searchname;*/ 
  /*echo $p_searchtype;*/ 
  if($p_searchtype=='GeneId'||$p_searchtype=='GeneSymbol') 
  { 
  $columnnos=mysql_num_fields($result1); 
  print "<table cellpadding=0 cellspacing=0 width=40% border=1 >"; 
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  print "<tr>"; 
   
  for ( $i=0; $i <$columnnos; $i++ )  
  { 
  if($i==2){next;}else{ 
  $column_name=mysql_field_name($result1,$i); /* field name */    
   print "<td align=left><b>".$column_name."</b></td>"; 
        }}} 
   print "</tr>"; 
  $total=0; 
  while ( $tuple = mysql_fetch_array($result1) ) /* process result row-by-row */ 
 {  
  print "<tr>"; 
  $total++; 
  for ( $i=0; $i <($columnnos); $i++ )  
  { 
   if($i<($columnnos-1)) 
   {if($i==2){next;}else{ 
   $column_value=$tuple[$i]; 
    print "<td align=left>".$column_value."</td>";} 
   } 
   elseif($i==3) 
   { 
   //while ( $tuple1 = mysql_fetch_array($SNP) ) 
   echo"$tuple1"; 
    //{$column_value1=$tuple1;} 
   $column_value=$tuple[3];            /* field value */ 
   $column_value1=$tuple1[3]; 
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   if($column_value=$column_value1) 
   {print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$tuple1."</a></td>";}  
   } 
 
   elseif($i==4) 
   { 
    $column_value1=$tuple[4]; 
   $column_value=$tuple[2];            /* field value */ 
   print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$column_value1."</a></td>";  
   } 
  } 
 } 
 mysql_free_result($result1);  
 echo ("<form method=get action=cleanDataGs.php>"); 
 echo ("<form method=get action=cleanDataGi.php>"); 
 if($p_searchtype==GeneId){ 
 echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": ". $total." records 
found</h3><br>"); 
 echo("<p align=\"left\"><a 
href=\"cleanDataGi.php?searchtype=$p_searchtype&searchval=$p_searchname\">Click here to 
download</a></p>");} 
 //echo("<p align=\"right\"><a href=\"cleanData.php?searchtype=GeneId\">Click here to 
download</a></p>");}  
  
 if ($p_searchtype==GeneSymbol){ 
  echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": ". $total." records 
found</h3>"); 
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  echo("<p align=\"left\"><a 
href=\"cleanDataGs.php?searchtype=$p_searchtype&searchval=$p_searchname\">Click here to 
download</a></p>"); 
} 
  
 if($p_searchtype==Disease) 
 { 
 $ncols=mysql_num_fields($result);/* How many columns (fields) */ 
 print "<table cellpadding=0 cellspacing=0 width=70% border=1 >"; 
 print "<tr>"; 
 for ( $i=0; $i <$ncols; $i++ )  
  { 
  if($i==4) 
   {next;} 
  else 
   { 
   $column_name=mysql_field_name($result,$i); /* field name */    
   print "<td align=left><b>".$column_name."</b></td>"; 
         } 
  } 
  } 
   print "</tr>"; 
 $total=0; 
 //$ncols2=mysql_num_fields($SNPunique) 
 //while ( $row2 = mysql_fetch_array($SNPunique) ) 
 //{ echo "$row2"; } 
  
 while ( $row = mysql_fetch_array($result) ) /* process result row-by-row */ 
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 {  
  print "<tr>"; 
  $total++; 
  for ( $i=0; $i <=($ncols); $i++ )  
   { 
    if($i<($ncols-1)) 
    { 
    if($i==4) 
     {next;} 
    else 
     { 
     $column_value=$row[$i]; 
     print "<td align=left>".$column_value."</td>"; 
     } 
    } 
    elseif($i==6) 
    { 
    $column_value1=$row[6]; 
    $column_value=$row[4];            /* field value */ 
    print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$column_value1."</a></td>";  
    } 
   } 
   } 
 mysql_free_result($result);  
echo ("<form method=get action=cleanData.php>"); 
if($p_searchtype==Disease) 
 { 
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 echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": ". $total." records found</h3>"); 
       echo("<p align=\"left\"><a 
href=\"cleanData.php?searchtype=$p_searchtype&searchval=$p_searchname\">Click here to 
download</a></p>"); 
 } 
if($p_searchtype==SNPId) 
  { 
  $ncols=mysql_num_fields($result2);/* How many columns (fields) */ 
  print "<table cellpadding=0 cellspacing=0 width=50% border=1 >"; 
  print "<tr>"; 
  for ( $i=0; $i <$ncols; $i++ )  
  { 
  if($i==3||$i==4){next;}else{ 
  $column_name=mysql_field_name($result2,$i); /* field name */    
   print "<td align=left><b>".$column_name."</b></td>"; 
        }}} 
   print "</tr>"; 
 $total=0;   
if($p_searchtype==SNPId) 
{ 
  while ( $row = mysql_fetch_array($result2) ) /* process result row-by-row */ 
 {  
  print "<tr>"; 
  $total++; 
  for ( $i=0; $i <($ncols); $i++ )  
  { 
   if($i<($ncols-1)) 
   {if($i==3||$i==4){next;}else{ 
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   $column_value=$row[$i]; 
    print "<td align=left>".$column_value."</td>";} 
   } 
   elseif($i==6) 
   { 
    $column_value1=$row[6]; 
   $column_value=$row[4];            /* field value */ 
   print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$column_value1."</a></td>";  
   } 
   } 
 } 
} 
 mysql_free_result($result2);  
if($p_searchtype==SNPId) 
{ 
 echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": ". $total." records found</h3>"); 
} 
if($p_searchtype==Year) 
  { 
  $ncols=mysql_num_fields($result3);/* How many columns (fields) */ 
  print "<table cellpadding=0 cellspacing=0 width=50% border=1 >"; 
  print "<tr>"; 
  for ( $i=0; $i <$ncols; $i++ )  
  { 
  if($i==4||$i==5){next;}else{ 
  $column_name=mysql_field_name($result3,$i); /* field name */    
   print "<td align=left><b>".$column_name."</b></td>"; 
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        }}} 
   print "</tr>"; 
 $total=0; 
if($p_searchtype==Year) 
{   
  while ( $row = mysql_fetch_array($result3) ) /* process result row-by-row */ 
 {  
  print "<tr>"; 
  $total++; 
  for ( $i=0; $i <($ncols); $i++ )  
  { 
   if($i<($ncols-1)) 
   {if($i==4||$i==5){next;}else{ 
   $column_value=$row[$i]; 
    print "<td align=left>".$column_value."</td>";} 
   } 
   elseif($i==6) 
   { 
    $column_value1=$row[6]; 
   $column_value=$row[4];            /* field value */ 
   print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$column_value1."</a></td>";  
   } 
   } 
 } 
} 
 mysql_free_result($result3);  
if($p_searchtype==Year){ 
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 echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": ". $total." records found</h3>");} 
if($p_searchtype==PMID) 
  { 
   $ncols=mysql_num_fields($result4);/* How many columns (fields) */ 
   print "<table cellpadding=0 cellspacing=0 width=50% border=1 >"; 
   print "<tr>"; 
   for ( $i=0; $i <$ncols; $i++ )  
    { 
     if($i==4||$i==5) 
      {next;}  
     else 
      { 
      $column_name=mysql_field_name($result4,$i); /* field 
name */    
      print "<td align=left><b>".$column_name."</b></td>"; 
            } 
    } 
  } 
   print "</tr>"; 
  $total=0; 
if($p_searchtype==PMID) 
{   
   while ( $row = mysql_fetch_array($result4) ) /* process result row-by-row */ 
   {  
   print "<tr>"; 
   $total++; 
   for ( $i=0; $i <($ncols); $i++ )  
    { 
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    if($i<($ncols-1)) 
     { 
     if($i==4||$i==5) 
      {next;} 
     else 
     { 
     $column_value=$row[$i]; 
     print "<td align=left>".$column_value."</td>"; 
     } 
     } 
    elseif($i==6) 
     { 
     $column_value1=$row[6]; 
     $column_value=$row[4];            /* field value */ 
     print "<td align=left><a target=\"_blank\" 
href='$column_value'>".$column_value1."</a></td>";  
     } 
    } 
   } 
} 
  mysql_free_result($result4);  
   if($p_searchtype==PMID) 
    { 
     echo ("<h3>Search for " .$p_searchtype ." ".$p_searchname.": 
". $total." records found</h3>"); 
    } 
//echo ("<br><left><h1><a href=Cytokine_associated_diseases.php> Back</a></h1></center>"); 
 
82 
 
// # Original PHP code by Chirp Internet: www.chirp.com.au 
//  # Please acknowledge use of this code by including this header. 
?> 
</BODY> 
</HTML> 
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Supplement 3 PHP code for downloading SNP data 
<?php 
function cleanData(&$str) 
  { 
    $str = preg_replace("/\t/", "\\t", $str); 
    $str = preg_replace("/\r?\n/", "\\n", $str); 
    if(strstr($str, '"')) $str = '"' . str_replace('"', '""', $str) . '"'; 
  } 
//import_request_variables('p','p_'); 
//  # file name for download 
  $filename = "website_data_" . date('Ymd') . ".xls"; 
 
//header('Content-Disposition: attachment; filename="downloaded.pdf"'); 
$searchname=$_GET["searchval"]; 
$searchtype=$_GET["searchtype"]; 
header("Content-Disposition:attachment;filename=\"$filename\""); 
header("Content-Type:application/vnd.ms-excel"); 
 
// Displaying Information. 
  $flag = false; 
  import_request_variables('p','p_'); 
  $db= mysql_connect("libra45.uits.iu.edu:3234","root","dis_snp10") or die(mysql_error()); 
  mysql_select_db('dacsdb',$db)or die("Cannot select database."); 
   
  //$result = mysql_query("SELECT * FROM Disease ORDER BY GeneSymbol") or die('Query failed!'); 
    $result = mysql_query("SELECT GeneId,GeneSymbol,Disease,SNPId,Year,PMID  FROM Disease WHERE 
$searchtype like '%$searchname%'") or die('Query failed!'); 
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  while(false !== ($row = mysql_fetch_assoc($result))) { 
    if(!$flag) { 
      # display field/column names as first row 
      echo implode("\t", array_keys($row)) . "\n"; 
 
 
 //echo("something unimportant")."\n"; 
      $flag = true; 
    } 
    array_walk($row, 'cleanData'); 
    echo implode("\t", array_values($row)) . "\n"; 
  } 
?> 
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Supplement 4: Perl code to retrieve SNP data. 
Perl code for parsing data from XML file: 
#!/usr/bin/perl 
$output="SNP.txt"; 
open(FILE, "412SNPfile.txt") or die("Unable to open file"); 
open(OUTPUT, ">$output") or die("Unable to open file"); 
@array=<FILE>; 
$ref=0; 
foreach $array (@array) 
{ 
if($array=~/\<Rs\srsId\=\"(.*)\"\ssnpClass/) 
{ 
$i=0; 
$j=0; 
print OUTPUT "\n\n$1\t"; 
} 
if($array=~/\<Het\stype\=.*value\=\"(.*)\"\sstdError\=\"(.*)\>/) 
{ 
if($1ne''&$2ne'') 
{ 
print OUTPUT "$1\t$2\t"; 
} 
else 
{ 
print "null \t null"; 
} 
} 
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if($array=~/\<Validation\s(.*)\>\<\/Validation\>/ || $array=~/\<Validation\s(.*)\>/ ) 
{ 
if($1ne'') 
{ 
print OUTPUT "$1\t"; 
} 
else 
{ 
print "null"; 
} 
} 
if($array =~/\<Ss\sssId.*/) 
          { 
            $ref_flag=0; 
            next; 
          } 
        if ($array=~/\<Sequence\sexemplar.*/) 
          { 
            $ref_flag=1; 
          } 
         if($ref_flag ==1) 
          { 
 if($array=~/\<Sequence\sexemplar.*/) 
 { 
            
 } 
 else 
 { 
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 $array=~s/\s+//g; 
 $array=~s/\n//g; 
 $array=~s/\<Seq5\>(.*)\<\/Seq5\>/$1/g; 
 $array=~s/\<Seq3\>(.*)\<\/Seq3\>/$1/g; 
 $array=~s/\<Observed\>(.*)\<\/Observed\>/$1/g; 
 $array=~s/\<\/Sequence\>//g; 
 print OUTPUT "$array\t"; 
  
         } 
 } 
if($array=~/\<Assembly\sdbSnpBuild\=\"(.*)\"\sgenomeBuild.*Label\=\"Celera\".*/) 
{ 
print OUTPUT "$1\t"; 
} 
if($array=~/\<Component\scomponentType.*chromosome\=\"(.*)\"\sstart.*Celera.*/) 
{ 
print OUTPUT "$1\t"; 
} 
if($array=~/\<MapLoc.*orient\=\"(.*)\"\sphysMapInt\=\"(.*)\"\sleftFlank.*/g) 
{ 
$j++; 
if($j==1) 
{ 
print OUTPUT "$2\t"; 
} 
} 
if($array=~/\<FxnSet\sgeneId\=\"(.*)\"\ssymbol\=\"(.*)\".*\sfxnClass\=\"(.*)\>/) 
{ 
88 
 
$i++; 
if($i==1) 
{ 
print OUTPUT "$1\t$2\t$3"; 
} 
} 
}   
 
 
 
 
 
 
1 
 
     Sushant Bhushan 
719, Indiana Avenue, Ste 319, Indianapolis, IN 46202                                                                                       
Phone (317) 522 – 6531, Email: sbhushan@iupui.edu 
             
 Master of Science in Bioinformatics (August, 2011) 
 5 year experience in Perl programming and  3 year experience in MySQL and PHP programming 
 Expertise in database design, development and management 
 Experience in Web design and development 
 Experience in software installation such as Partek, MEME and working in UNIX environment 
 6 months Hands on experiences with high throughput genomic data 
 
OBJECTIVE: Seeking a full–time position in Bioinformatics which involves software development, 
database development or data analysis. 
EDUCATION:  
 M.S, Bioinformatics, Indiana University, School of Informatics, Indianapolis  
 GPA – (3.4/4.0), June 2011 
 B-Tech, Biotechnology, Visvesvaraya Technological University, Belgaum, India  
 GPA – (3.4/4.0), May 2006.  
SKILL SET: 
Information Technology: 
 Languages & Scripts:  JAVA, Perl, Python, Ruby on Rails, R, Bioconductor, MySQL, HTML, XML, 
CGI, C. 
 Platforms: UNIX, LINUX, Macintosh, Windows XP/2000/Vista/7. 
 Statistical tools: SPSS, SAS 
 Tools: dbSNP, RefSeq, Hap Map, UCSC Genome Browser, Ensemble, Blast,  MEME, TRANSFAC, 
Gene GO, Clustal W, Modeller9.1, Spdbv, PHYLIP, PAUP  
 Pathway building tool : MetaCore 
 Database: MySQL, SQL, Oracle  
 
RESEARCH WORK EXPERIENCE: 
INDIANA UNIVERSITY: 
 Graduate Research Assistant – Indiana University School of Informatics, Indianapolis (May 09 – 
Present) 
 As part of thesis work developed the DACS-DB database available online at 
www.iupui.edu/~cytosnp and worked on to classify SNP data into disease class and non-
disease class.  
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 Graduate Teaching Assistant– Dr. Narayanan B. Perumal, Introduction to Informatics (I-501 
course),  Indiana University School of Informatics, Indianapolis (January 2010 – May 2010) 
 Scientific Programmer – CCBB, IU School of medicine, Indianapolis (Sept 2010 – Oct 2011)   
 High through put data analysis. Worked on ChIP-Seq data analysis for determining 
association between promoter regions and H3K4Me3 peaks  
 Lecturer – KLE College of engineering and technology, Belgaum, India, (Aug 2007 – May 2008)   
ACADEMIC & COURSE PROJECTS: 
 Machine Learning and Pattern Recognition: 
 “Classification of Cytokine SNP data with SVM” – Application of SVM method for 
classification of disease and non-disease data of Cytokine SNPs. Application of RBF, MLP, 
and Perceptron was previously applied to test and train the SNP data into disease and 
non-disease class.  
 Translational Bioinformatics:  
 “Performed the class Analysis of protein structure data to determine the docking 
potential of proteins and drugs with docking and comparing it to machine learning 
approach to determine which approach is better for screening better drug to interact to 
protein.  
 Introduction to Bioinformatics: 
 “De-novo motif prediction in NF-KB pathways” – Application of MEME tools for the 
prediction of de-novo motifs associated in NF-KB pathways and comparing it to 
TRANSFAC database to discover de-novo motifs in microarray data.  
 Introduction to Informatics: 
 “Online patient data record”- Built a user interactive tool for doctors to retrieve online 
patient health data. Patient biographic data was stored in MySQL database. A user-
interactive interface was built with PHP for accessing the patient data. 
ACTIVITIES: 
 AAI-2010 (American association of Immunologists), Baltimore, MARYLAND. 
o Poster : “DACS-DB: A dissemination and curation model to cure illness” in June 2010 
 IUPUI Research day, IUPUI, Indianapolis, INDIANA  
o Poster : “DACS-DB: A dissemination and curation model to cure illness” in April 2010 
 ISBB-2006, 15-17 December, Bhubaneswar, ,INDIA 
o  Poster was awarded Best Poster in the conference titled “Sequence Analysis of H5N1 & 
H1N1 for Ascertaining Test System” 
 Member of Indiana Clinical and Translational Sciences Institute 
